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ABSTRACT 
Aims: The overall aim of this thesis was to investigate the risk of cancer mortality and 
survival after cancer diagnosis based on migration background and socioeconomic position in 
Sweden. We studied the effects of country of birth and level of education, as a proxy for 
socioeconomic position, on mortality due to all-site cancer (and some common specific 
cancers), trends in overall survival after cancer diagnosis (all sites and selected cancer sites), 
and  all-cause and excess mortality in breast cancer patients by stage at diagnosis. 
 
Materials and methods: The data used in this thesis are from a nationwide dataset, the 
Migration and Health Cohort, which was specifically designed to address health status among 
immigrants and among socially and economically deprived population in Sweden. In this 
cohort, information was retrieved through linkage between several national Swedish registers 
(Studies I–III). Based on country of birth, we followed individuals from the total population 
in the years 1961–2009 (Study I), cancer patients 45 years of age and older in the years 1961–
2009 (Study II), and breast cancer patients by stage at diagnosis in the years 2004–2009 
(Study III). The outcomes were cancer mortality (Study I) and survival (Studies II and III). 
We calculated mortality rate ratios (MRRs) (Study I), age-standardized rates (ASRs) (Study 
I), hazard ratios (HRs) (Studies II and III), relative risk ratios (RRRs), and relative excess 
rate (RER) (Study III) with 95% confidence intervals (CIs) using Poisson (for MRR and 
RER), Cox, and multinomial logistic regression models, respectively.  
Results: We observed a downward trend in all-site ASRs over the past two decades in men 
but no change in women regardless of country of birth (Study I). In comparison with Sweden-
born men, all-site cancer mortality was slightly higher in foreign-born men, with men born in 
Angola, Laos, and Cambodia having the highest risk. Among women, a similar risk was 
observed in foreign-born and Sweden-born individuals (Study I). However, the findings 
varied across different cancer sites; foreign-born individuals had lower risks of colon, 
prostate, and breast cancer mortality but higher risks of lung and cervical cancer mortality 
compared with Sweden-born individuals (Study I). All-site cancer mortality increased with 
decreasing level of education (Study I). A similar pattern of level of education was observed 
with regard to all-cause mortality in breast cancer patients (Study III). Overall, after the year 
2000, overall survival was lower in foreign-born cancer patients, who were on average 4 
years younger at the time of diagnosis, compared with cancer patients born in Sweden (Study 
II). The results were almost the same independent of sex, duration of residence, and age at 
diagnosis. The overall survival trends for prostate and breast cancers were also similar to the 
trend for all-site cancers (Study II). Not surprisingly, survival decreased with increasing 
tumor size, number of lymph nodes involved, presence of metastasis, comorbidity, and 
anatomic stage in breast cancer patients, particularly among foreign-born patients (Study III). 
We observed a higher risk of stage II tumor (stage I as baseline) among all foreign-born 
breast cancer patients and patients born in Asia compared with those born in Sweden (Study 
III). In addition, a poorer survival was observed among all foreign-born breast cancer patients 
with stages III–IV cancer and also patients born in Asia and Southern Europe with stages III 
and IV cancer, respectively, compared with breast cancer patients born in Sweden (Study 
III).  Analyses taking into account reason for migration showed that refugee patients with 
breast cancer had a higher risk of both all-cause and excess mortality, compared with 
Sweden-born patients. In the stratified analysis by stage, the risks were prominent in 
advanced stages (III–IV) of disease. The higher risks of all-cause and excess mortality were 
not statistically significant. Furthermore, compared with non-refugee patients, we found non-
significantly higher risks of both all-cause and excess mortality among refugee women with 
advanced-stage cancer. 
Conclusions:  Country of birth is an important determinant of risk of cancer mortality and 
survival after cancer diagnosis. Increased mortality risk with decreasing level of education, 
remains a major risk indicator for these events. The decreased overall survival among 
foreign-born patients after the year 2000 and poor prognosis among foreign-born breast 
cancer patients with advanced stages of the disease need further investigation to fully 
understand the reasons behind these disparities. 
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1 INTRODUCTION 
1.1 MIGRATION 
Definition 
Migration is any movement of an individual or a group of individuals from one place to 
another. There is no clear universal definition for the term „migrant‟ but it generally applies 
to a person moving from one country to another country or region temporarily or 
permanently [1, 2]. Depending on the reasons for migration and the legal status of the 
migrants in the host country, migrants are classified into different groups. 
 
Types of migrants 
Asylum seekers and refugees 
Refugees include persons who have left their countries of origin as their lives and security 
are threatened for political, social, religious, or ethnic reasons. An asylum seeker is a 
person who is seeking to be identified as a refugee, but has not yet received formal refugee 
status [1]. Worldwide there were 19.5 million refugees at the end of 2014 (about 7% of all 
international migrants) and it is estimated that half of all refugees are under 18 years of age 
[3, 4].  
 
Labor migrants 
Labor migration refers to movement of persons across countries or within one country for 
the purpose of work [1]. In 2014, approximately 50% (105 million) of international 
migrants worldwide were labor migrants [5]. 
 
Documented versus undocumented migrants  
Documented migrants are individuals who have entered a country legally and have the right 
to remain according to the admission regulations. Conversely, undocumented migrants are 
those who do not have a legal permit or authorization to reside, work, or study in the host 
country [1, 6]. According to a report from the International Organization for Migration, 
about 10% to 15% of the world‟s international migrants were undocumented in 2010 [7].  
 
In this thesis, we first defined migrants as individuals living in Sweden legally who were 
born abroad, without considering the reasons for their migration. We then performed 
additional analysis taking into account the reason for migration. 
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1.2 MIGRATION WORLDWIDE 
According to the World Health Organization (WHO), there are an estimated 1 billion 
migrants in the world of whom 232 million are international migrants (3.2% of the global 
population) and 740 million are domestic migrants [8-10]. International migration has 
increased, particularly in the past three decades. The number of international migrants 
increased from 75 million in 1965 to 105 million in 1985 (2.3% to 2.7% of the global 
population). Between 1990 and 2013, the number of international migrants increased from 
154 to 232 million (2.9% to 3.2% of the global population) with the largest growth rate in 
Europe. In 2013, European countries hosted more than 72 million international migrants 
(9.8% of the European population) [9, 11-15]. Recently, at least 7 million persons have fled 
the ongoing conflict in Syria and around 3 million have been displaced [16]. More than 
51% of international migrants worldwide were living in 10 countries in 2013. The USA 
hosted the largest number of international migrants (46 million) followed by the Russian 
Federation (11 million), Germany (10 million), Saudi Arabia (9 million), and the UK and 
the United Arab Emirates (8 million each) [13]. It is estimated that the number of 
international migrants will reach 405 million worldwide by 2050 [17]. 
 
1.3 MIGRATION IN SWEDEN 
The immigrant population has increased in Sweden over time, dramatically influencing 
population growth (Figures 1 and 2). In 2015, 17% (1,676,264) of the total population of 
Sweden was born outside the country compared to 6.7% in 1970 [18]. This figure does not 
include undocumented migrants, such as asylum seekers and other migrants without a 
residence permit, who are not included in any registry or in population statistics [19]. 
Sweden has experienced several waves of migration over time. Before 1930, Sweden was a 
country of net emigration, mainly to North America. After 1930, the net flow of migration 
in Sweden changed from emigration to immigration [20], with immigration to Sweden 
increasing due to several causes including social, labor, religious, and political factors. In 
the 1940s, there was an increase in net flow of immigration, mostly from Europe, including 
refugees after the Second World War. In the 1950s and 1960s, large numbers of labor 
migrants arrived in Sweden from the Nordic countries, Southern Europe, and Turkey [19, 
20]. During the 1970s and 1980s, the immigration pattern changed: refugees mainly arrived  
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from Asian countries and Latin America because of unemployment and economic 
difficulties. Political factors have also led to a rise in immigration; high numbers of 
refugees arrived in Sweden fleeing from Latin American dictatorships and the Islamic 
revolution in Iran in the 1970s, and the disintegrating former communist countries, 
including Yugoslavia and the Soviet Union, and civil war in Iraq and Somalia during the 
1990s and early 2000s [19, 20]. Recently there has been a new wave of migration to 
Sweden from Syria due to civil war [21]. Since 2010, the majority of asylum seekers have 
come from Middle Eastern and African countries, including Syria, Somalia, Eritrea,  Iraq, 
Afghanistan, and Serbia [22]. 
The 10 largest immigrant populations (first generation) in Sweden in 2015 were from 
Finland, Iraq, Syria, Poland, Iran, the former Yugoslavia, Somalia, Germany, Turkey, and 
 Norway (Figure 3) [23]. 
 
 
 
Figure 1: Proportion of the foreign-born population in Sweden between 1970 and 2015   
(Source: Statistics Sweden). 
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Figure 2: The Swedish population between 1970 and 2015 by migration status (Sweden-
born and foreign-born individuals) (Source: Statistics Sweden). 
 
 
 Figure 3: The 10 largest groups of foreign-born populations by sex in Sweden in 2015 
(Source: Statistics Sweden). 
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1.4 MIGRANT HEALTH 
With increasing numbers of migrants worldwide, migrant health has become an important 
global public health issue [24]. Migration itself has become an interesting topic worldwide 
in terms of population projection and the disparities in the distribution of diseases between 
migrants and the native population in the host country. The effect of immigration on health 
status is controversial. Some studies have shown that migrants, despite poorer access to 
healthcare, have better health compared to the native population [25, 26]. This has been 
termed the “healthy immigrant” effect. According to several epidemiological studies, some 
immigrants have better economic status and are healthier, in comparison to the general 
population in their country of origin [27, 28]. On the other hand, there have been reports 
that some groups of immigrants experience much higher rates of disease and poorer health 
status than that of natives [29, 30]. In Sweden, the rate of diseases among immigrants 
compared with native Swedes varies by country of origin and type of disease. Compared 
with native Swedes most immigrant groups have higher risk for coronary heart disease [31-
34], post-traumatic stress disorder [35], depression and psychotic disorders [36] and lower 
risk for cancers of breast, endometrium, ovary, prostate [37-39] and child and young adult 
type 1 diabetes [40, 41].  
The complex issue of migrant health is an important public matter related not only to the 
ethical implications of unequal access to healthcare but also to healthcare costs. Health 
problems are often directly linked to deprivation and poor living conditions [30]. A 
society‟s social cohesion in terms of economic sustainability and political cooperation is 
affected to large extent on the health of its members and its healthcare system [11, 42]. 
Because migrants generally live in poor areas and have economic difficulties, they may be 
most vulnerable to health problems. The health profiles, values, and beliefs of migrants 
often differ from those that prevail in the host country. These factors often have an impact 
on the usage of health-related services by migrants [43].  
Displacement and migration are critical phases in an individual‟s life. In addition to its 
influence on health, migration has both short- and long-term social and economic effects. 
These effects have been extensively investigated and many studies highlight their 
complexity and variation between and among individuals/groups. Some of the social effects 
of migration are briefly discussed below. These effects can have an indirect impact on an 
individual‟s life and health. 
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Language barriers and the role of the authorities  
Proficiency in the local language is a crucial factor for social engagement in the 
community. Access to translators and professionals acting as cultural mediators is essential 
for ensuring good understanding and communication [44, 45]. Language courses and 
interracial social activities are important in the process of integration and belonging, both at 
work and in the community as a whole [46]. Difficulty in communicating due to poor 
language skills has been associated with acculturation problems and mental health issues 
[47-49]. Evidence suggests that immigrants holding a permanent residence permit have 
significantly better language skills compared to those with a temporary permit [47]. 
Communication problems between health providers and patients have been associated with 
unnecessary consumption of resources, difficulty in following providers‟ instructions and 
understanding various side effects, decreased use of primary care with increased focus on 
the emergency department, and insufficiently regular follow-ups [50-53]. Furthermore, 
immigrants with poor language skills are less able to seek and gain other sources of health 
information such as from the media or internet which may have a negative effect on their 
health status in terms of both prevention and treatment [54, 55]. Poor language skill can 
affect utilization of health care system. Immigrants in Sweden have been reported to utilize 
health care system less frequently than native Swedes [56-58]. In absence of suitable 
communication, their access to wider care is often hindered [59]. 
The feeling of belonging and improvement of mental health conditions have been shown to 
be proportional to the degree of support from the local authorities [60, 61]. Healthcare 
providers‟ lack of knowledge of cultural differences in health-related issues can be another 
factor that negatively affects immigrants‟ health [55]. In a Canadian study, immigrant 
women from several countries defined health and health-related issues very differently 
compared to providers. They felt that providers were unaware and disrespectful of these 
differences, and were therefore dissatisfied with the care provided [62]. Taking these 
differences into consideration, healthcare providers should aim to actively create a 
healthcare environment based on mutual respect and understanding [55].     
Sense of discrimination 
It has been shown that migrants from developing countries are more vulnerable to 
discrimination after entry to the host country [63]. In a report about racial discrimination, it  
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was highlighted that up to 80% of Afro-Americans have experienced discrimination based 
on their race/ethnicity [64]. Further, in the USA and Canada, discrimination has been 
reported to be common in educational centers, both in schools and English language centers 
[65]. Discrimination and harassment have a negative impact on psychological health. At an 
individual level, a person‟s self-confidence and ability to interact with others can be 
reduced. At the societal level, discrimination has a direct negative impact on integration and 
acculturation [65-67]. The incidence of discrimination toward immigrants is argued to be 
much higher due to underreporting [68]. Immigrants in Sweden are identified to have a 
poorer mental health conditions than natives [69, 70]. Factors such as racial discrimination 
[71], unemployment  [72], and lack of access to skills training programs [73] have been 
shown to be associated to the poor health among immigrants. 
Length of residence and acculturation   
During and shortly after the process of migration, poorer health conditions have been 
observed in some migrant groups, compared with the local-born population [55], however 
this difference decreases with time until conditions reach the same level as in natives after 
around 8 years of residence [74]. Integration of immigrants has also been shown to affect 
access to healthcare. The individual‟s capacity to adapt to the new sociocultural structure in 
the host country, and to reflect on self-identity [75-77], are factors that can influence 
health-related issues. Some immigrants groups in Sweden has been shown to have a greater 
difficulties for a psychological adaptation in Sweden, and that is shown to affect their 
health condition negatively [78, 79].  
Lifestyle and living conditions differ between labor migrants and refugees. Labor migrants 
may integrate more easily than refugees, because they already have an occupation when 
they arrive in the host country. They have also already chosen a host country which they 
believe will benefit them in some way. There are factors that might be less favorable to 
labor migrants with respect to health conditions compared to refugees. Labor migrants are 
exposed to less work-related stress and occupational environmental hazards [11, 80-82]. 
However, access to healthcare is lower among refugees compared with labor migrants [74, 
83]. Further, there are clear differences in terms of psychological conditions. The 
prevalence of mental distress and depression has been shown to be higher among refugees 
compared with labor migrants [84, 85], especially among women and those who are older, 
lack social support, or have experienced previous trauma or more stress since migration 
[86]. 
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1.5 MIGRATION AND CANCER 
Background 
According to the WHO, cancer is a growing global problem with increasing incidence and 
mortality. Cancer is a leading cause of death worldwide. Despite the fact that more than 
30% of cancers are potentially preventable, there were approximately 14 million new cases 
of cancer, 8.2 million deaths, and 32.6 million persons living with cancer within 5 years of 
diagnosis in 2012 [87, 88]. Those numbers were additionally increased during 2015 
with17.5 million cancer cases worldwide and 8.7 million deaths [89]. It is expected that the 
number of annual cancer cases will further  rise to 22 million within the next two decades 
[87]. Deaths due to cancer worldwide are projected to increase continuously, to an 
estimated 11 million in 2030. Cancers of the lung, liver, stomach, colon, and breast are the 
leading causes of cancer deaths [87, 88]. In 2012, the five most common types of cancer 
diagnosed among men were lung, prostate, colorectal, stomach, and liver cancers and 
among women were breast, colorectal, lung, cervical, and stomach cancers [87]. Overall, 
20% of deaths in Europe are due to cancer with more than 1.7 million deaths annually [90]. 
Of note, 57% of new cancer cases, and 65% of cancer deaths occur in low- and middle-
income countries [91] with few or no resources for prevention, diagnosis, or treatment of 
the disease [90].  
In Sweden the annual number of cancer cases reported to the Cancer Registry has increased 
during the last two decades. The average annual increase is 1.9% for men and 1.3% for 
women [92]. Prostate, female breast, skin (except melanoma), colon, and lung cancers are 
the most common types of cancer in Sweden [25]. Cancer is the second most common 
cause of mortality in Sweden (26% of deaths among men and 22% among women) [93] and  
contributes to 60% of the total burden of disease [94].  
Survival is a key measure of the efficiency of healthcare systems and is defined as the time 
between cancer diagnosis and death [95]. Survival trends can help both in the formulation 
of strategies for cancer control and in the assessment of their effectiveness [96]. An 
increasing trend in cancer survival with calendar time for most types of cancers and in most 
countries is well documented [88, 96-98]. Despite increasing survival trends, substantial 
and persistent differences exist within and between countries. A goal of the World Cancer 
Declaration is to achieve major improvements in survival worldwide by 2020 [96].  
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Regardless of resource level, all countries can implement the four basic components of 
cancer control: prevention, early detection, diagnosis and treatment, and palliative care 
[90]. A national cancer strategy for Sweden was proposed in 2009 with the aim of 
improving survival and quality of life, and reducing geographical differences, among 
cancer patients [96]. Among European countries, Sweden has a relatively high overall 
cancer survival rate for both men and women [99]. 
 
Migration and cancer incidence  
All-site cancer 
Compared with the host population, lower all-cancer incidence rates have been observed 
among migrants from Southern Europe living in the Netherlands [100], Middle Eastern 
migrants living in Denmark [101], North Africans living in the Netherlands and Denmark 
[100, 101], Asians living in the UK [102], South-East Asians living in the UK and in the 
Netherlands [100, 103-105], and South American migrants and migrant men from Africa in 
the Netherlands [100]. However, no differences in all-cancer incidence have been observed 
among migrant men from Eastern Europe living in Germany [106], compared with 
German-born men. 
 
Stomach cancer  
Studies of stomach cancer incidence comparing migrants with the host population have 
shown higher incidence rates of stomach cancer among migrants from Scandinavia living in 
the USA [107] and Eastern European migrants and men-born in Southern Europe and 
Turkey living in Germany [106, 108], compared with US-born and German-born 
populations, respectively. However, a lower risk of stomach cancer has been observed 
among migrants from South-East Asia living in the UK and the Netherlands [100, 104], 
from Southern Europe and Turkey living in Germany [109], and Asian men living in the 
UK [102], compared with the host populations. In another study, no statistically significant 
differences in stomach cancer incidence were observed between migrant men from Asia 
and UK-born men [110]. 
 
Colon cancer  
The majority of studies investigating the incidence of colon cancer have shown a lower risk 
among migrants compared to the host population in different countries. A lower colon  
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cancer incidence has been reported among migrants from Southern Europe and Turkey 
living in Germany and the Netherlands [100, 109], from Eastern Europe living in Denmark 
[101], Africa, North Africa, and South America living in the Netherlands [100], the Middle 
East living in Denmark [101], and South-East Asia living in the UK and the Netherlands 
[103, 104], and also among Chinese men and Filipino living in the USA [111] and men 
born in Eastern Europe living in Germany [106], compared with the host populations. 
However, no statistically significant differences in colon cancer incidence have been 
observed among migrants from Asia in the Netherlands [100] and women born in Eastern 
Europe living in Germany [106], compared with the host population. 
 
Lung cancer  
Lung cancer incidence comparing immigrants with the host populations has been shown to 
be lower among migrants from South-East Asia living in the UK [103, 104], from South 
America and North Africa in the Netherlands [100], and Scandinavia in the USA [107], as 
well as among men born in South-East Asia living in the UK and the Netherlands [100, 
105] and women from Eastern Europe living in Germany [106] and from Southern Europe 
and Turkey living in Germany and the Netherlands [100, 109]. However, a higher lung 
cancer incidence has been observed among migrant men from Southern and Eastern Europe 
living in Germany [106, 109], compared with German-born men. 
 
Breast cancer 
Female breast cancer incidence rates among immigrants compared with the host 
populations have frequently been shown to be lower among migrant women from Southern 
and Eastern Europe living in Germany [106, 109], from Southern Europe and Turkey living 
in the Netherlands [100, 112], from the Middle East and Eastern Europe living in Denmark 
[101], from China and the Philippines living in the USA [113], from Africa living in the 
Netherlands [100], from North Africa living in the Netherlands and Denmark [100, 101, 
112], from Asia living in the UK [102], from South America living in the Netherlands [100, 
112], and from South-East Asia living in the UK [103-105]. However, no statistically 
significant differences in breast cancer incidence have been observed among Japanese 
migrant women living in the USA [113] and African and South American migrant women 
in the UK [114], compared with the host population. 
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Cervical cancer 
Compared with Dutch-born women, higher cervical cancer incidence was found among 
migrant women from South America and North Africa in the Netherlands [100, 115]. 
However, a lower risk of cancer of the cervix has been observed among Asian and South-
East Asian women in the UK [102, 104], compared with UK-born women. 
 
Prostate cancer 
Prostate cancer incidence among immigrants compared with the host population has been 
shown to be lower among migrant men from Southern Europe and Turkey living in 
Germany and the Netherlands [100, 109], from Asia and North Africa living in the 
Netherlands [100], and from South-East Asia living in the Netherlands and the UK [100, 
103, 104]. However, higher risk of prostate cancer has been observed among migrant men 
from South America in the Netherlands [100], compared with Dutch-born men. 
 
Migration and cancer incidence in Sweden 
All-site cancer 
Studies in Sweden indicated lower all-cancer incidence rates among all migrants [116], 
migrants from Africa, Asia, and South America [116], and the Middle East [117], compared 
with Sweden-born individuals. 
 
Stomach cancer  
Studies of stomach cancer incidence comparing migrants with Sweden-born individuals 
have shown a higher incidence among all migrants as well as specifically among migrants 
from Asia [116], South America [118], and Estonia [119] and among migrant women from 
East and South-East Asia [120], whereas lower risks of stomach cancer have been observed 
among migrant men from the Middle East [117] and women from Turkey [118]. 
 
Colon cancer  
Lower incidence of colon cancer have been reported among migrants from Asia [116], 
South America [118], and the Middle East [117], and among Turkish women [118], 
compared with Sweden-born individuals. 
 
 
 
 
 12 
 
Lung cancer  
Lower lung cancer incidence rates have been reported among migrants from the Middle 
East [117], women born in South America [116], and Asian Arab women [121], compared 
with Sweden-born individuals. Higher lung cancer risk has been observed among all 
migrant men [116], migrant men from Estonia [119] and Eastern Europe [118, 121], and 
women from Turkey [118, 120], Denmark, Norway, and Finland [121]. However, in 
another study, no difference in lung cancer incidence was observed between Asian and 
Sweden-born men [116]. 
 
Breast cancer  
Female breast cancer incidence rates among migrant women compared with Sweden-born 
women have frequently been shown to be lower among all migrants [37, 116, 122-124], 
migrant women from Africa, Europe, and Northern Europe [37], Latin America [37, 122], 
Asia [37, 116], South America [116, 122, 124], East Asia and South-East Asia [122, 124], 
the Middle East [117, 122], Estonia [119], the Baltic countries, Poland, Russia, Greece, 
Finland, Norway [122], and Turkey [122, 124].  
 
Cervical cancer 
Compared with women born in Sweden, a higher cervical cancer incidence was found 
among all migrants [39, 116], migrant women from Poland, Bosnia [39], Eastern Europe 
[120, 125, 126], South-East Asia, South and Central America [120, 126], and Denmark and 
Norway [120, 125, 126]. However, a lower risk was observed among migrants from Africa 
[39, 116], Turkey, Southern Europe [39], East Africa and South-Central and Western Asia 
[126], the Middle East [39, 117, 126], Asia [116, 125, 126], South America [116], and 
Finland [39, 125], compared with women born in Sweden.  
 
Prostate cancer 
A lower prostate cancer incidence has been shown among all migrants [38, 116, 127, 128] 
and migrants born in Africa [116], the Middle East [117, 127], Asia [116, 127], Turkey, and 
Chile [127], compared with native Swedes. However, migrants born in Central Africa and 
the Caribbean had higher risks of prostate cancer [38], compared with Sweden–born men. 
Moreover, no differences in prostate cancer incidence have been observed between South 
American migrants and men born in Sweden [116].  
 
  13 
 
The cause of the observed differences in cancer incidence between immigrants and natives 
is multifactorial and could be explained by several factors including barriers to healthcare 
access [101, 114, 116, 129], environmental [37, 38, 102, 117] and genetic factors [38, 100], 
dietary habits [104, 105, 109, 114], lifestyle patterns [37, 100-102, 104, 105, 115, 126, 
130], smoking [101, 105, 109, 116], alcohol consumption [102, 105], screening uptake  
[101, 104, 105, 112, 114-116, 126, 129, 131-133], reproductive behavior [39, 109, 112, 
117, 126], human papillomavirus (HPV) prevalence [39, 115, 126], socioeconomic factors 
[104, 105, 116, 117], and the healthy migrant effect [126]. 
 
Migration and cancer mortality  
Cancer mortality rates among migrants differ from those of the host population [25, 106, 
134] and, similar to cancer incidence, show large variability across cancer sites, country of 
origin, and host country [135].  
 
 All-site cancer 
Compared with the host population, lower all-cancer mortality rates have been observed 
among migrants from Southern Europe living in the Netherlands [134, 136], from Eastern 
Europe living in Germany, Italy, and the UK [106, 137-140], from North Africa living in 
France, the Netherlands, and Italy [134, 136, 140, 141], from West [142] and East Africa 
living in the UK [137, 143, 144], from Asia living in the UK and Spain [137, 145], from 
South Asia living in Canada [146], from South-East Asia living in France and the UK [137, 
144, 147], from South and Central America living in the Netherlands and the UK [134, 136, 
143, 144], from Suriname living in the Netherlands [148], and from Turkey living in 
Belgium, Denmark, France, and the Netherlands [149]. On the other hand, higher mortality 
rates due to all cancers were observed among migrants from South Eastern Europe and 
Eastern Europe living in Australia [150], and migrant men from West Africa living in the 
UK [137, 143] and from Eastern Europe living in Spain [145], compared with the native 
populations. No differences in all-cancer mortality have been observed among migrants 
from the Middle East living in the UK, compared with UK-born individuals [137].  
 
Stomach cancer  
Studies of mortality due to stomach cancer comparing migrants with the host population in 
the USA [151] and Australia [150] have reported a higher risk among immigrant groups.  
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This is also the case among Turkish migrants in France and the Netherlands [149]. A higher 
mortality rate was also reported among migrant men from Eastern Europe living in 
Germany [106, 138, 152] and from South and Central American countries living in the UK 
[144], as well as among migrant women from Southern European countries in the 
Netherlands [136] and from Asia in the UK [110]. Nevertheless, there have been reports of 
lower stomach cancer mortality among migrant men from North Africa living in France 
[141] and from East Africa living in the UK [143], compared with the host population.  
 
Colon cancer  
The majority of studies investigating mortality due to colon cancer have shown a lower risk 
among migrants compared to the host population in different countries. The lower mortality 
risk due to colon cancer has been reported among Southern European migrants living in the 
Netherlands [134], North African migrants in the Netherlands and France [134, 141, 153], 
South-East Asian migrants in France and the UK [147, 154], South and Central American 
migrants in the Netherlands and the UK [134, 143], and all migrants in Australia [150, 
155]. Migrant men from West Africa living in France [142], from East Africa and the 
Middle East living in the UK [137], and from Eastern Europe living in Germany [106], and 
foreign-born women from East Africa living in the UK [143] also have lower colon cancer 
mortality rates compared with the host population. However, a higher colon cancer 
mortality rate was observed among migrant men from China compared with their US-born 
counterparts [156].  
 
Lung cancer 
Results from the majority of studies of lung cancer mortality have also shown lower 
mortality rates among immigrants compared with the host populations. Mortality risk has 
been shown to be lower among migrants in the USA [151], migrants from Southern Europe 
living in the Netherlands [134, 136], from West and  East Africa [137, 143] and Asia [137] 
in the UK, from South and Central America in the Netherlands and the UK [134, 143], from 
Turkey in the Netherlands and France [149], and Cuba in the USA [157], compared with 
the host populations. Lower lung cancer mortality rates have also been reported among all 
migrant women in Australia [155] and women from Eastern Europe living in Germany and 
the UK [106, 137], from North Africa living in the Netherlands and France [134, 136], and 
from the Middle East living in the UK [137], as well as migrant men from North Africa 
living in the Netherlands and France [134, 136, 141, 153], and foreign-born men from West  
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Africa living in France [142] compared with the host populations. However, a higher risk 
has been reported among migrant men from Southern Europe living in Spain [145], from 
Eastern Europe in Germany [106, 139], and from China in the USA [156], as well as 
migrant women from North Africa living in France [153], compared with the host 
populations. 
 
Breast cancer 
Female breast cancer mortality risk among migrants compared with the host population has 
been shown to be lower among migrant women from Southern Europe living in the 
Netherlands [134, 136], from Eastern Europe living in Germany and the UK [106, 137, 
139], from North Africa in the Netherlands and France [134, 136, 141, 153], from Asia in 
the UK [110], from South-East Asia in France and the UK [147, 154], from South America 
in the Netherlands and the UK [134, 143], and from Turkey in the Netherlands and France 
[149]. Among migrant women from West Africa, a higher mortality risk due to breast 
cancer was observed in studies from the UK [137, 143], but a lower mortality risk was 
found in France [142], compared with the host populations. 
 
Cervical cancer 
Compared with the host population, a higher in mortality risk due to cancer of the cervix 
was found among migrant women in Italy [140] and South and Central American countries 
living in the UK [143], and among South-East Asian migrants in France and the UK [147, 
154]. However, a lower cervical cancer mortality risk has been reported among migrant 
women from Southern Europe living in the Netherlands [134], from South and Central 
America in the Netherlands [134], and from North Africa in the Netherlands and France 
[134], and among foreign-born women from East Africa in the UK [143], compared with 
the host populations.  
 
Prostate cancer 
Mortality risk due to prostate cancer among migrants compared with the host population 
has been shown to be lower among migrants from the British Isles and continental Europe 
living in Australia [155], from Eastern Europe living in Germany and the UK [106, 137, 
139], from North Africa in the Netherlands and France [134], from East Africa, the Middle 
East, and Asia living in the UK [137], from South-East Asia in France and the UK [147, 
154], and from Cuba in the USA [157]. However, a higher mortality risk has been reported  
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in the UK among migrants from West Africa [137, 143] and from South and Central 
America [143, 144], compared with UK-born men.  
 
Migration and cancer mortality in Sweden 
Studies of cancer mortality among immigrants in Sweden have been limited to two studies, 
one of all-site cancer [158] and the other of cancer of the cervix [125]. 
 
All-site cancer 
Higher cancer mortality risks among foreign-born immigrant men from Bosnia, Somalia, 
Yugoslavia, Denmark, and Finland have been reported in Sweden, compared with native 
Swedes [158]. The results have been less consistent among women. Higher mortality was 
only observed among women from Denmark, whereas some immigrant populations such as 
women from Iran and Germany had lower cancer mortality [158].  
 
Cervical cancer 
Higher cervical cancer mortality among foreign-born women from Denmark and Norway 
was observed in Sweden. However, a lower risk among foreign-born women from Iran and 
no differences among all immigrants in Sweden were found [125].  
 
Differences in cancer mortality among migrants compared with the host population have 
been considered to be related to various factors such as the healthy migrant effect [108, 
134, 136, 141, 142], the return of migrants in poor health to their country of origin prior to 
death (“salmon bias”) [108, 141, 142], pre-migration risk factors (country of origin effect) 
[139], living conditions [108, 138], differences in diets [108, 134, 136-139, 141, 142, 150, 
152, 153], smoking habits (particularly for lung cancer) [106, 108, 134, 136, 137, 139, 141-
145, 150, 154], alcohol consumption [106, 138, 139, 141-144, 153, 154], genetic factors 
[139, 143, 147, 153], viral causes [139, 144, 153], cultural factors [141, 153], the 
prevalence of Helicobacter pylori infection (for stomach cancer) [106, 108, 138], 
reproductive behavior (for breast and cervical cancers) [139, 141, 150, 154], birth rates (for 
breast cancer) [106], access to healthcare and improved treatment options [152], earlier 
detection [152], health-seeking behavior [138], physical activity [139], sociocultural 
barriers (affecting uptake and quality of clinical treatment) [108], and cancer screening (for 
breast, prostate and cervical cancers) [137]. 
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Migration and mortality after cancer diagnosis (survival) 
The increasing trend in cancer survival with calendar time for most cancer types has been 
shown in many countries [88, 96-98, 159], although clear differences have been observed 
within [160] and between countries [96, 161].  
 
All-site cancer 
A study in Denmark showed no significant differences in overall survival for all cancer 
patients between migrant and Danish-born women [162].  
 
Stomach cancer 
One-year survival was higher in all migrant patients [163], but mortality for stomach cancer 
patients was lower among migrants from Morocco, Suriname, and Turkey, compared with 
local-born Dutch [163, 164]. 
 
Colon cancer 
A US study demonstrated poorer overall survival among foreign-born patients with colon 
cancer, compared with those born in the USA [165]. However, studies in Denmark [162] 
and the Netherlands [166] have shown no significant differences in survival for colon 
cancer patients among migrants compared with native Danish and Dutch, respectively.  
 
Lung cancer 
No significant differences in overall survival for patients with lung cancer were observed 
between migrants and native Danes [162]. 
 
Breast cancer 
Most migration studies in breast cancer patients have been limited to specific ethnic groups 
in the USA, and have shown that, for each disease stage, survival is poorer among Afro-
American compared with Caucasian women [167]. After adjustment for covariates 
including stage, the results of a study conducted in the USA indicated that Native 
Americans and migrants of Asian or Central and South American ethnicity had higher risks 
of mortality after a breast cancer diagnosis compared with non-Hispanic white women 
[168]. Other studies in the USA showed better survival for patients with breast cancer 
among foreign-born Hispanic women, compared with US-born Hispanic women [169]. 
Studies in the Netherlands indicated lower 5-year survival for patients with breast cancer  
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among all migrants, compared with native-born Dutch [163]. However, mortality among 
patients with breast cancer was higher in women from Morocco [163] and lower in those 
from Surinamese and Indonesia [163, 164], compared with local-born Dutch women. A 
study in Norway has demonstrated poorer survival after breast cancer diagnosis for migrant 
women from Sri Lanka, Pakistan, and Somalia compared with Norwegian women [170]. 
 
Cervical cancer 
Compared with native Dutch women, survival for patients with cervical cancer was 
improved among migrant women in the Netherlands [166]. 
 
Migration and mortality after cancer diagnosis (survival) in Sweden 
Breast cancer 
Lower 5-year survival for female breast cancer patients was observed among Estonian 
women compared with the total Swedish population [171]. Case fatality of breast cancer 
was also lower in patients diagnosed after 50 years of age among migrants compared with 
Sweden-born women [37]. Specifically, poor survival was found for lobular breast cancer 
among foreign-born patients from low-risk non-European countries (Indians, East Asians, 
Latin Americans, and Africans) [124].  
 
Prostate cancer 
For prostate cancer patients, no differences in survival have been shown among all 
immigrants in Sweden [127], but immigrant men from Estonian [171] and from the Middle 
East, Asia, North Africa, and Chile had higher survival rates [120, 127].  
 
Other cancers 
Lower 5-year survival was observed for cancers of the colon among Estonian women, and 
of the lung among Estonian men, compared with the Swedish patients. However, higher 
rates were observed for cancers of the stomach and colon among men [171]. 
 
To explain why there is variation in cancer survival among migrants compared to host 
populations, one need to understand the complexity of the disease. Cancer survival is 
reflected by several hallmarks, important for both development and treatment of cancer. 
Access to high-quality healthcare affects cancer survival. To be able to survive cancer, both 
prevention and detection are important, and are directly linked to access to healthcare 
which may differ between these groups [135, 162, 164, 170-172]. Poor access to the local  
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healthcare system has been reported in foreign-born patients compared to the host 
population and this factor has been correlated with poorer cancer survival [161, 165].  
Early detection, which often corresponds to detection of tumors at an early stage, is an 
important prognostic factor [88, 96, 97, 160, 168]. When a cancer is detected at early stage, 
the patient has a much higher chance of responding to treatment and thereby increased 
probability of survival [161, 163, 169, 171, 173]. Racial differences in detection of breast 
cancer have been reported. It is known that Afro-American women are generally diagnosed 
with breast cancer at a later stage and thus have a poorer prognosis [167, 174].  
Various screening programs have been recognized as important tools for successful and 
early detection and thus better prognosis (for breast, cervical, and prostate cancers) [120, 
124, 160, 163, 164, 166, 169, 170, 173, 175-178]. Differences in screening program 
attendance have been reported. Migrants have been shown to attend screening calls in a 
smaller extend compared to the host population [115, 133, 168, 177-184]. Reduced 
awareness and sociocultural differences are factors, among many others, associated with 
lower screening program attendance [96, 177, 178, 185].  
It is known that comorbidities affect overall differences in survival [88, 96, 165, 173]. 
Comorbidity differences between immigrants and natives, if present, may explain the 
differences in cancer survival between these groups [97]. An individual‟s socioeconomic 
position (SEP) is a crucial factor for promoting better survival [159]. Lower SEP 
unavoidably affects lifestyle factors important for improved survival [168, 170]. Genetic 
variation is another important factor for both cancer incidence and survival [186], and 
partly explains the differences in incidence and survival between groups of different genetic 
background through factors such as mutation pattern and response to treatments [164]. 
Finally, the occurrence of salmon bias can also lead to an overestimation of survival rate 
among immigrants, which does not reflect the reality [166, 187].  
 
Conclusion 
The incidence of cancer among immigrants has been extensively studied by a number of 
researchers and the available literature is comprehensive. The vast majority of studies 
investigating the incidence of cancer have shown that migrants are less likely to develop 
cancer compared to the host population in several countries. This is especially true for 
cancers of the colon, breast, and prostate. For other cancer sites, the pattern is unclear and a  
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large variability across cancer sites and studies is observed. 
For cancer mortality, a large variability across cancer sites, country of origin, and host 
countries has been shown. The majority of studies investigating mortality have shown that 
migrants have lower risks of mortality due to cancers of the colon, lung, breast, and 
prostate. The results of very few studies in Sweden indicate higher all-sites cancer mortality 
among male migrants, whereas no clear pattern has been observed among women. 
Studies investigating cancer survival among migrants are also limited. The results show no 
differences in overall survival for all-site cancer patients between migrants and their local-
born counterparts. This is especially true for lung cancer patients due to the short survival 
period after diagnosis. For colon and breast cancer patients, the majority of studies have 
demonstrated lower survival among migrants, whereas improved survival has been 
observed among migrants with cervical cancer compared to the host population. In Sweden, 
the few studies that have been conducted show poorer survival for cancers of the breast and 
colon among migrant women and of the lung among migrant men, compared with Sweden-
born women and men respectively. However, better survival is observed for cancers of the 
prostate, stomach, and colon among migrant compared with Sweden-born men. 
 
Limitations of previous studies concerning cancer mortality and survival of migrants in 
Sweden 
Although the medical system in Sweden is suitable for carrying out epidemiological studies 
focusing on cancer mortality and survival among immigrants, few such studies had been 
conducted at the time of the start of our study. Furthermore, such previous studies had 
several limitations.  
In studies of cancer mortality, either SEP or duration of residence in the new environment, or 
both, has often not been taken into consideration. Other weaknesses include age limited and a 
short follow-up period. Moreover, some previous studies on cancer mortality used the 
indirect method for standardization of mortality ratios (SMRs) to compare rates between 
migrants and Swedes. The use of this method was based on a small number of cases in the 
migrant groups. The main limitation of SMR is that it must be consistent across all ages. If 
the studied group is not consistent, the values will not be comparable. In addition, there has 
been a lack of information concerning cancer mortality in Sweden. Several studies have been 
conducted but either focusing on all-site cancer or cervical cancer alone. To our knowledge,  
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none of the other types of cancer that have been studied in our project have yet been 
investigated by others.  
Previous cancer survival studies did not perform separate analyses with respect to year of 
diagnosis, age at diagnosis, sex, and time since immigration to Sweden. We evaluated trends 
in mortality after cancer diagnosis for cancers at any site and at the leading cancer sites in 
Sweden (colon, lung, stomach, prostate, female breast, and cervix). In addition, survival for 
cancers (at studied sites (Study II)) in respect to country of birth is relatively new approach 
that has not been studied earlier in a comprehensive way, only partly. 
To our knowledge, our study of breast cancer diagnosis and mortality by tumor stage and 
migration background (Study III) is the first to evaluate breast cancer risk and mortality by 
tumor characteristics and country of birth taking into consideration the effect of comorbidity. 
Our knowledge regarding the effects of immigration on cancer mortality and survival at all 
and any leading sites in Sweden, namely colon, lung, stomach, prostate, female breast, and 
cervix, is limited. One way to determine the effect of environmental and lifestyle factors on 
diseases is to study the disease occurrence among immigrants and compare it to that of the 
residents in the host country. 
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2 AIMS 
 
2.1 GENERAL AIM 
The overall aim of this thesis was to investigate the trends in cancer mortality and survival 
for all-site cancer and some common specific cancer types (colon, lung, stomach, prostate, 
breast, and cervical cancers) in Sweden, with particular reference to country of birth and level 
of education.  
 
2.2 SPECIFIC AIMS 
2.2.1 Mortality (Study I) 
 To evaluate the risk of mortality due to all-site cancer and cancer of selected sites by 
country of birth in women and in men (Study I). 
 To investigate the effect of level of education on all-site cancer mortality by country 
of birth and sex (Study I). 
 
2.2.2 Survival (Studies II and III, and extra analysis) 
 To investigate the effect of country of birth on trends in all-cause mortality after 
cancer diagnosis (all-site cancer and cancer of selected sites) by year of diagnosis, 
age at diagnosis, and time since immigration to Sweden in women and men (Study 
II). 
 
 To detect disparities in survival after breast cancer diagnosis among female breast 
cancer patients by disease stage at the time of diagnosis, country of birth (Study III), 
and reasons for migration (extra analysis). 
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3 MATERIALS AND METHODS  
 
3.1 DATABASES 
The data used in these three studies were available from a nationwide dataset, the Migration 
and Health Cohort (M&H Co.) [188], which was built by linkage of several Swedish 
national demographic and health registers through the 10-digit unique Swedish personal 
identity number (PIN). The M&H Co. is provided by the National Tax Board for all 
individuals who have resided in Sweden for more than 1 year since 1947. The PIN has been 
replaced by serial numbers and the key code is kept by Statistics Sweden to ensure 
confidentiality. The M&H Co. was created to specifically address health status among 
immigrants and their offspring to facilitate studies on diabetes, cancer, and cardiovascular 
and psychiatric diseases in Sweden (Figure 4). 
 
 
 
Figure 4: The Migration and Health Cohort. 
 
Parts of the M&H Co. that are used in this thesis were obtained from the following 
registries.  
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3.1.1 The Total Population Register (TPR) 
Population registration in Sweden was originally started by the Church of Sweden with 
continuous information dating back to the 17th century [189]. Between 1961 and 1967 
population registration was based on printed cards sent from the county administrative 
boards to Statistics Sweden [190]. The TPR in Sweden was officially established in 1968 
by Statistics Sweden, which contains demographic information, country of birth, and data 
on emigration and immigration [190]. Most persons (who were born in or who moved to 
Sweden) are registered in the TPR and their details are updated continuously until the date 
they emigrate or die [191].  
The register includes the following variables: 
 Name  
 Address 
 PIN and co-ordination number 
 Country of birth 
 Citizenship 
 Civil status 
 Spouse, children, parents, legal guardians, and adoption  
 Property, parish, and municipality of registration 
 Immigration to Sweden including date of immigration, country of origin, and 
reasons for migration (with incomplete information for a large number of 
immigrants)  
 De-registration information (emigration from Sweden and address abroad, or death 
and burial site) 
 Sex  
 Age  
The TPR in Sweden covers the entire population and is updated on a daily basis. Although 
there is still both under-coverage (lack of information about birth and immigration) and 
over-coverage (lack of information about death and emigration), the exact magnitude of 
these is unknown [189]. 
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3.1.2 The Swedish Cancer Register 
The Cancer Register from the Swedish National Board of Health and Welfare contains data 
on diagnoses of cancers since 1958 and covers the whole population. Malignant diseases 
are coded using the seventh and ninth revisions of the International Classification of 
Diseases (ICD-7 and ICD-9 respectively). The ICD-7 codes are available for whole period 
of time from 1958 by the National Board of Health and Welfare. "According to Regulations 
by the National Board of Health and Welfare (SOSFS 2006:15) all physicians in hospitals 
and other establishments for medical treatment under public or private administration in 
Sweden must report all malignant and certain benign tumors to the Cancer Register. 
Furthermore, pathologists and cytologists separately report every tumor diagnosed from 
surgically removed tissues, biopsies, cytological specimens, bone marrow aspirates, and 
autopsies. Thus, the majority of cases are notified twice, in separate reports. Only persons 
that have official residency in Sweden are included in the Cancer Register" [192]. Since the 
mid-1980s, six regional registries have been associated with the oncology centers in each 
medical region of Sweden (Stockholm, Gothenburg, Linkoping, Lund–Malmo, Umea, and 
Uppsala) where registration, coding, and major check-up and correction are performed. 
This regionalization implies close contact between the registry and the reporting physician, 
which in turn simplifies the task of correcting and checking the material [192]. 
There are three different types of information: 
 Patient data including PIN, sex, age, and place of residence. 
 Medical data including site of tumor (ICD-7 codes available for the entire period 
from 1958 to 2009), histological type, basis of diagnosis, date of diagnosis, stage 
(collected since 2004), reporting hospital and department, reporting 
pathology/cytology department, and identification number for the tissue specimen. 
 Follow-up data, date of death, cause of death, and date of migration. 
Diagnosis was based on clinical diagnosis and x-ray or autopsy examination [193] and all 
cases were histologically verified [127, 193]. The completeness of this registry regarding 
verified cases is considered to be close to 100% [194, 195]. 
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3.1.3 The Cause of Death Register 
The Cause of Death Register (from the Swedish National Board of Health and Welfare) 
contains data on the date and the main cause of death from 1961 onwards, and is updated 
annually [196, 197]. This register is based on seventh, eighth, ninth, and tenth revisions of 
the ICD [198]. The Cause of Death Register includes data for all deceased persons who at 
the time of death were registered in Sweden, whether the death occurred within or outside 
Sweden. Persons who had not yet received a residence permit or those who died during a 
temporary stay in Sweden, stillbirths, and emigrants from Sweden who are no longer 
registered in the country are not included in the register.  
The register contains: 
 PIN 
 Place of death  
 Main and contributing cause of death  
 Date of death  
 Sex, age, and marital status  
Autopsies provide valuable information regarding cause of death, however the proportion 
of autopsies has decreased from 50% during the 1970s to 12% in recent years [199, 200]. 
The non-reporting rate for the Cause of Death Register has been estimated to be less than 
2% [93, 98]. 
 
3.1.4 The Swedish National Inpatient Register 
The Swedish National Inpatient Register, also known as the Hospital Discharge Register, 
contains data on comorbid diseases in hospitalized patients. The register contains data on 
the main diagnosis and up to eight secondary diagnoses, coded according to ICD-9 during 
the years 1987–1996, and 10th version of ICD from 1997. The National Inpatient Register 
was established in 1964 with nationwide coverage in 1987. The Swedish National Board of 
Health and Welfare check the quality and completeness of data available in the National 
Inpatient Register on a regular basis. The diagnoses for most diseases included in this 
register are valid in 85–95% of cases [201]. 
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3.1.5 The National Population and Housing Censuses  
The National Population and Housing Censuses collected data on sociodemographic 
variables such as education level in Sweden between 1960 and 1990. The information was 
updated every 5 years from a questionnaire delivered by post to every household in 
Sweden. In addition to demographic and socioeconomic data, household information was 
collected including information on housing, employment, number of residents, and 
overcrowding [202]. 
 
3.1.6 LISA 
The longitudinal integration database for health insurance and labor market studies (LISA) 
from Statistics Sweden provides information on the highest attained level of education; 
since 1990 the information is updated annually. The LISA includes all persons aged ≥16 
years what were registered in Sweden at the end of each year. The database includes 
demographic, occupational, and socioeconomic variables such as individual, family, and 
capital income, level of education and marital status [198, 203].  The level of education is 
updated annually from many different sources, most of which are other registers from 
Statistics Sweden or other authorities. Since 2000, a questionnaire has been sent to foreign-
born residents with an unknown level of education to request this information [204]. 
 
3.2 ETHICAL ISSUES 
The studies in this thesis were approved by the regional boards of the Ethics Committee in 
Stockholm, Sweden (reference no. 2005/726-31 and amendment 2009/2033-32). Linkages 
have been completed via the PIN by Statistics Sweden and the National Board of Health 
and Welfare. To ensure that data anonymity and confidentiality for research are maintained, 
the PINs have been replaced by serial numbers with the code held at Statistics Sweden. 
 
3.3 METHODS 
The data for all three studies are derived from the M&H Co. and there are two main groups 
in all studies; cohort members born outside Sweden are referred to as foreign-born 
individuals and those born in Sweden are referred to as Sweden-born individuals. The 
analyses were stratified by sex. 
 
 28 
 
3.3.1 Study cohorts and follow-up 
Study I  
The study cohort consisted of all individuals (7,109,327 men and 6,958,714 women) living 
in Sweden at any time between January 1, 1961 and December 31, 2009.  
The cohort was followed from the beginning of 1961, the date of birth for Sweden-born 
individuals, or the date of immigration for foreign-born individuals, whichever occurred 
last, until the date of death due to cancer (see Table 1 for ICD codes), the date of first 
emigration, or the end of follow-up (December 31, 2009), whichever occurred first. 
 
Table 1: International Classification of Diseases (ICD) codes for cancer death according to 
calendar period of study. 
 ICD-7 ICD-8 ICD-9 ICD-10 
 (1961–1968) (1969–1986) (1987–1996) (1997–2009) 
All-site cancers 140–209 140–209 140–208 C00–C97 
Lung cancer 162–163 162–163 162–163 C33–C34 
Colon cancer 153 153 153 C18 
Stomach cancer 151 151 151 C16 
Breast cancer 170 174 174 C50 
Cervical cancer 171 180 180 C53 
Prostate cancer 177 185 185 C61 
ICD-7, -8, -9, and -10, seventh, eighth, ninth, and tenth revisions of the International 
Classification of Diseases, respectively. 
 
Study II  
The study cohort consisted of all cancer patients (787,751 men and 768,357 women), aged 
45 years or older, living in Sweden at any time between January 1, 1961 and December 31, 
2009. The cohort members were followed from the date of cancer diagnosis (see Table 1 
for ICD-7 codes), until the date of death due to any cause, the date of first emigration, or 
the end of follow-up (December 31, 2009), whichever occurred first. 
 
Study III  
The study cohort consisted of 35,268 female patients with a first primary diagnosis of 
invasive breast cancer (see Table 1 for ICD-7 code) after excluding non-melanoma skin  
cancer (ICD-7 code: 191) among women living in Sweden at any time between January 1, 
2004 and December 31, 2009. The women were followed from the date of breast cancer  
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diagnosis, until the date of death due to any cause, the date of first emigration, or the end of 
follow-up (December 31, 2009), whatever occurred first. 
 
3.3.2 Exclusion criteria 
In Studies II and III, foreign-born cancer patients residing in Sweden for <5 years before 
diagnosis were excluded from the study cohort for the following two reasons: to avoid 
including patients who had been diagnosed prior to immigration, and to minimize detection 
bias resulting from patients‟ possibly limited access to healthcare. 
 
3.3.3 Outcome variables 
In Study I, the main outcome of interest was death due to cancer (see Table 1) as an 
underlying cause. In Studies II and III, the main outcome of interest was death due to any 
cause. In Study III, anatomic stage of breast cancer at the time of diagnosis was also an 
outcome; staging of breast cancer is based on three components, the size of the tumor (T), 
the number of lymph nodes involved (N), and the presence of metastasis (M). According to 
the TNM classification, invasive breast cancer is divided into four main anatomic stages 
(1–IV) [205]. Stage at diagnosis is classified as missing if information any of the variables 
T, N, or M are missing or unidentifiable. 
 
3.3.4 Exposure variables 
The main exposures of interest in this thesis were country of birth (for all three studies) and 
level of education (for Studies I and III). For Studies I and III, place of birth for foreign-
born patients was classified into six continents, which were further subdivided into 19 
world regions, as defined by the United Nations Population Division as follows: Africa 
(East, Central, North, Southern, and West Africa), Asia (East, South-Central, South-East, 
and Western Asia), Europe (Eastern, Northern, Southern, and Western Europe), Latin 
America (Caribbean, Central America, and South America), North America, and Oceania 
(Australia/New Zealand, Melanesia, and Micronesia/Polynesia) [206]. Only countries with 
five or more cases of deaths (cancer death for Study I and all-cause death for Studies II and  
III) were reported in order to ensure enough statistical power. In Studies I and III, the 
association was also investigated between the highest attained education level as a proxy 
for SEP and the outcome, when applicable, using census data before 1990 and the LISA  
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from 1990 onwards. The level of education was divided into four categories: 0–9 years 
(compulsory school education), 10–12 years (upper secondary school), more than 12 years  
(post-secondary school), and unknown. In Study II, the analysis was stratified by duration 
of residence for foreign-born individuals, the age at diagnosis, and the calendar year of 
diagnosis. For duration of residence of 5 years or more, foreign-born patients were 
categorized into three groups (5–14, 15–29, and 30+ years). Age at cancer diagnosis was 
categorized into nine groups of 5-year intervals (45–49, 50–54, …, 80–84, and 85+ years). 
The calendar year of diagnosis was categorized into five groups (1961–1969, 1970–1979, 
1980–1989, 1990–1999, and 2000–2009). In Study III, for patients diagnosed with breast 
cancer, the association was also investigated between the T, N, M, stage (I–IV), comorbidity 
and the outcome among foreign-born and Sweden-born patients. Using an updated version 
of the Charlson‟s comorbidity index (CCI), comorbidity burden was assessed [207, 208]. 
We categorized patients according to comorbidity burden through information on diagnosis 
of diseases other than breast cancer using the index. We further calculated the CCI score at 
least 7 years before the date of breast cancer diagnosis to assess patient comorbidity (Table 
2). The CCI scores were grouped into four categories (0, 1, 2 and ≥3). 
 
Table 2: Specification of Charlson comorbidities, International Classification of Disease 
10th revision (ICD-10) codes, and Charlson weight. 
Comorbidities ICD-10 Charlson 
weight 
Myocardial infarction I21-I22, I252 1 
Congestive heart failure I099, I110, I130, I132, I255, I420, I425-I429, I43, I50, P290 1 
Peripheral vascular disease I70-I71, I731, I738-I739, I771, I790, I792, K551, K558-K559, Z958-Z959 1 
Cerebrovascular disease G45-G46, H340, I60-I69 1 
Dementia F00-F03, F051, G30, G311 1 
Chronic pulmonary disease I278-I279, J40-J47, J60-J67, J684, J701, J703 1 
Rheumatic disease M05-M06, M32- M34, M315, M351, M353, M360 1 
Peptic ulcer disease K25-K28 1 
Mild liver disease B18, K700-K703, K709, K713-K715, K717, K73-K74, K760, K762-K764, 
K768-K769, Z944 
1 
Diabetes without chronic 
complication 
E100-E101,E106, E108-E111, E116, E118-E121,E126,E128-
E131,E136,E138- E141,E146,E148-E149 
1 
Diabetes with chronic 
complication 
E102-E105,E107,E112- E115,E117,E122-E125,E127,E132-
E135,E137,E142-E145,E147 
2 
Hemiplegia/paraplegia G041, G114, G801-G802, G81-G82, G830-G834, G839 2 
Renal disease I120, I131, N032-N037, N052-N057, N18-N19, N250, Z490- Z492, Z992 2 
Any malignancy including 
lymphoma and leukemia, 
excluding melanoma of skin 
C00-C26,  C30-C34, C37-C41, C43,  C45-C58, C60-C76, C81-C85, C88, 
C90-C97  
2 
Moderate or severe liver 
disease 
I850, I859, I864, I982, K704, K711, K721, K729, K765-K767  3 
Metastatic solid tumor C77-C80 6 
HIV/AIDS B20-B22, B24 6 
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3.3.5 Explanatory variables 
Study I  
Age at follow-up, education level, and calendar period at baseline were considered as 
confounders in the analysis in Study I, when applicable. Age at follow-up was divided into 
19 groups of 5-year intervals (0–4, 5–9, …, 85–89, and 90+ years). Calendar period at 
baseline was divided into 10 groups of 5-year intervals (1961–1965, …, and 2006–2009). 
In all three studies the highest attained level of education was used as an indicator of SEP 
and level of education was divided into four categories: 0–9 years, 10–12 years, >12 years, 
and unknown. 
 
Study II 
Education level was divided into four categories as described above. 
 
Study III 
Age at breast cancer diagnosis, educational level, medical county of residence, and 
comorbidity were considered as confounders in the analysis in Study III, when applicable. 
Age at breast cancer diagnosis was categorized into 14 groups (<25, 25–29, 30–34, … , 75–
79, 80–84, and 85+ years). Educational level was divided into four categories as described 
above. Medical county of residence was geographically divided into the six healthcare 
regions in Sweden: Stockholm, Gothenburg, Linkoping, Lund–Malmo, Umea, and Uppsala 
[192]. The CCI is described above. 
 
 
3.4 STATISTICAL ANALYSIS 
3.4.1 Age-standardized rate 
Age-standardized rates (ASRs) of cancer mortality between 1961 and 2009 stratified by 
country of birth and sex (Study I) were calculated from the numbers of new cases divided by 
the estimated numbers of person-years at risk. To adjust for age (age distribution differences 
between immigrants and Sweden-born individuals) in the study population, ASRs were 
directly calculated using weighted averages based on the world population as the standard, 
assuming equal distribution in each age group. ASRs are reported per 100,000 person-years. 
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3.4.2 Poisson regression 
In Study I, mortality rate ratios (MRRs) and 95% confidence intervals (CIs) were calculated 
to assess the association between country of birth or level of education and cancer mortality 
as a measure of relative risk using Poisson regression models. In Study III, relative survival 
ratio (RSR) was calculated to estimate breast cancer-specific survival. In addition, we 
modeled relative excess rate (RER) of death and 95% CIs by stage at breast cancer 
diagnosis and country of birth, based on collapsed data using exact survival times [209]. In 
Poisson regression the outcome variable is assumed to follow the Poisson distribution, 
which describes a discrete probability distribution for the counts of events that occur 
randomly in a given interval of time. Follow-up time is separated into time intervals and a 
separate rate is measured for each interval, thereby allowing for the probability that the rate 
is changing over time, but the assumption of Poisson regression is that the rate is constant 
within each time interval. As in Poisson distribution, the mean is equal to its variance.  
 
3.4.3 Cox proportional hazards regression 
The multivariable Cox proportional hazard regression model was used to calculate the 
hazard ratios (HRs) and 95% CIs of all-cause mortality after cancer diagnosis in Studies II 
and III. The Cox proportional hazards model is the most commonly applied model in 
medical time-to-event studies. It assumes a multiplicative association between the 
underlying hazard functions and a log–linear function of the covariates. The model further 
assumes proportionality of hazards; the hazard curves are assumed to be parallel on a log 
scale and the hazards for patient subgroups are proportional over the follow-up period. The 
validity of the proportional hazards assumption was visually assessed across different 
groups of patients by plotting the log (–log (survival)) against log (time) by group. 
 
3.4.4 Multinomial logistic regression 
Relative risk ratios (RRRs) and 95% CIs of risk of anatomic breast cancer stage at the time 
of diagnosis were calculated using the multinomial logistic regression model (study III). In 
the analysis, anatomic stage I was considered as baseline (stages II, III, and IV vs. I). 
Multinomial logistic regression is a method that is useful to model the probability with 
categorical outcome variables. One of the possible categories of the categorical outcome is 
considered as baseline, and the model allows any other category to be compared with the 
baseline category. 
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4 RESULTS 
 
4.1 STUDY I: CANCER MORTALITY BY COUNTRY OF BIRTH, SEX, AND 
SOCIOECONOMIC POSITION IN SWEDEN, 1961–2009 
We followed a cohort of all individuals (7,109,327 men and 6,958,714 women) living in 
Sweden at any time between January 1, 1961 and December 31, 2009. Among this group, 
1,950,551 (13.9%) were born outside Sweden. During the study period (1961–2009), there 
were 464,690 deaths due to cancer among men (29,142 foreign-born men) and 417,258 
deaths due to cancer among women (29,537 foreign-born women). 
All-site cancer mortality declined with increasing education level independent of sex and 
country of birth (p for trend <0.0001).  
Compared with Sweden-born men, foreign-born men had an overall 5% higher all-site 
cancer mortality risk after adjustment for age and calendar period at baseline (MRR=1.05, 
95% CI 1.04–1.07), whereas similar risks were found for foreign-born and Sweden-born 
women (MRR=1.0, 95% CI 0.98–1.01). Among foreign-born men from Europe, the highest 
MRR was observed among those born in Bosnia followed by men born in the Netherlands, 
Finland, Denmark, Estonia, Hungary, and the former Yugoslavia with a 10% higher risk, 
and only a 5% higher risk was observed for those born in Norway. Men born in other parts 
of Europe had similar MRRs to Sweden-born men (except for men born in Greece with a 
26% reduced risk). By contrast, the all-site cancer mortality risks were 15% and 10% lower 
in men born in Asia and North America, respectively, compared with Sweden-born men. 
The lowest MRRs with 35% reduced risk were observed among men born in Iran and India. 
The only immigrant groups with an increased MRR from these continents were men born in 
Laos and Cambodia with more than a 3-fold and 2-fold increased risk, respectively. 
Overall, men born in Africa had a similar MRR to men born in Sweden whereas African 
men born in Angola had a 5-fold higher risk.  
Overall, foreign-born women had lower or similar MRRs compared to Sweden-born 
women. Women born in Iceland, Mexico, Denmark, Norway, and Romania had higher 
MRRs compared to women born in Sweden. The lowest mortality risk was observed among 
women born in Iran, Greece, Spain, Switzerland, Turkey, and Syria.   
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Specific cancer types  
Colon cancer 
In comparison to Sweden-born individuals, men and women born outside Sweden had a 9% 
lower risk of colon cancer mortality. In all studied countries of birth, we observed lower or 
similar risks of colon cancer mortality among men and women, except men born in Latvia 
(40% elevated risk) and women born in Denmark (30% elevated risk). 
 
Lung cancer 
Lung cancer mortality was higher in foreign-born individuals of both sexes compared with 
Sweden-born individuals. At the country level, we observed higher or similar risks among 
men born in all studied countries except for those born in Iran (55% reduced risk). Women 
born in almost all countries in Europe had higher risks of lung cancer but women born in 
Asian, African, and Latin American countries had similar or lower risks. 
 
Stomach cancer 
Overall foreign-born individuals had similar risks of stomach cancer mortality compared 
with Sweden-born men and women. In the analysis by specific birth country, compared 
with Sweden-born men, we observed higher risks of stomach cancer among men born in 
Estonia, the former Soviet Union, Chile, Bosnia, Poland, and the former Yugoslavia, and 
lower or similar risks among men born in the remaining countries studied. Women in most 
parts of Asia and Northern Europe had higher risks of stomach cancer mortality whereas 
women born in the rest of the world had similar risks compared with Sweden-born women. 
 
Prostate cancer 
Foreign-born men overall had a 30% lower risk of prostate cancer mortality, in comparison 
with men born in Sweden. At the country level, we observed lower risks in almost all 
countries studied.  
 
Breast cancer 
Compared with Sweden-born women, foreign-born women had an overall 8% lower risk of 
breast cancer mortality. A decline in risk was also observed among women born in all 
studied countries except Canada, Iraq, Mexico, Belgium, and the USA, in whom the risks 
were higher. 
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Cervical cancer 
The risk of cervical cancer mortality was higher in foreign-born women compared to 
women born in Sweden. In the analysis by specific birth country, we observed higher risks 
in women born in almost all studied countries with the highest risk in those born in 
Vietnam, followed by India, Romania, Latvia, Denmark, Norway, and the former 
Czechoslovakia. 
 
4.2 STUDY II: TRENDS IN MORTALITY AFTER CANCER DIAGNOSIS: A 
NATIONWIDE COHORT STUDY OVER 45 YEARS OF FOLLOW-UP IN 
SWEDEN BY COUNTRY OF BIRTH  
We followed a cohort of all cancer patients (787,751 men and 768,357 women), aged 45 
years or older, living in Sweden at any time between January 1, 1961 and December 31, 
2009. Among this group, 109,915 (7.06%) were born outside Sweden. During the study 
period (1961–2009), there were 604,035 deaths due to any cause among men and 540,138 
all-cause deaths among women (33,593 and 34,174 foreign-born men and women, 
respectively).  
In the analysis stratified by calendar year of diagnosis, age at diagnosis, and duration of 
residence, for the period between 1970 and 1990, all-cause mortality was lower among 
foreign-born cancer patients compared with those born in Sweden. Similar results were 
observed for both sexes regardless of duration of residence and age at diagnosis. After 
1990, the all-cause mortality risk disparity between patients born inside and outside Sweden 
started to increase gradually over time, though the patterns were inconsistent among 
foreign-born groups with different durations of residence, until 2000 when the increase 
became more evident, particularly among men. We observed an almost identical pattern for 
cancer-specific mortality among all cancer patients. Furthermore, the all-cause mortality 
trend for prostate and breast cancers were similar as all-site cancer patients. 
 
4.3 STUDY III: BREAST CANCER DIAGNOSIS AND MORTALITY BY TUMOR 
STAGE AND MIGRATION BACKGROUND IN A NATIONWIDE COHORT 
STUDY IN SWEDEN 
We followed a cohort of all 35,268 patients with a first primary diagnosis of invasive breast 
cancer after excluding non-melanoma skin cancer among women living in Sweden at any 
time between January 1, 2004 and December 31, 2009. Among this group, 4,232 patients  
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(12.0%) were born outside Sweden. During the study period (2004–2009), there were 4,178 
deaths due to any cause (418 foreign-born women).  
Among patients with breast cancer, all-cause and excess mortality decreased with 
increasing level of education regardless of country of birth (p for trend <0.05). All-cause 
and excess mortality for breast cancer patients increased with increasing tumor size, level 
of lymph node involvement, and CCI score (p for trend <0.0001) but with a more 
pronounced increased excess mortality. All-cause mortality was higher about 6-fold and 11-
fold in Sweden-born and foreign-born patients with metastatic disease, respectively, 
compared with patients without metastatic disease. In the excess mortality analyses the 
pattern was even more pronounced.  
After adjusting for age at diagnosis, education level, county of residence and CCI score, 
and considering stage I as baseline, the entire group of foreign-born patients and those born 
in Asia specifically had a 9% and 25% higher risk of stage II tumor, respectively, compared 
with Sweden-born patients. Regarding anatomic stage, we observed that all-cause and 
excess mortality for breast cancer patients increased with increasing anatomic stage both 
among Sweden-born and foreign-born women (p for trend <0.0001). We found a higher risk 
of dying among foreign-born women overall if their tumor was diagnosed at advanced stages 
III–IV (HR=1.25, 95% CI 1.00–1.56 and RER=1.30, 95% CI 1.03–1.64), compared with 
Sweden-born patients. Adjustment for age at diagnosis, education, county of residence, and 
CCI score reduced the risk of dying to 20% (HR=1.20, 95% CI 0.95–1.51 and RER=1.21, 
95% CI 0.95–1.55). The risk was highest among women born in Southern Europe (HR=1.36, 
95% CI 0.77–2.40 and RER=1.36, 95% CI 0.76–2.46) and Asia (HR=1.50, 95% CI 0.87–
2.63 and RER=1.47, 95% CI 0.83–2.63). 
The 1- and 2-year RSRs of breast cancer patients were decreased by increasing tumor stage 
regardless of country of birth. The RSRs were lower for foreign-born patients if the tumor 
was diagnosed at stages III or IV. In addition, the 1- and 2-year RSRs for patients with 
missing information about stage were similar to those for patients with stages I and II 
cancer regardless of country of birth. 
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4.4 ANALYSIS OF REASON FOR MIGRATION IN BREAST CANCER 
PATIENTS 
We further performed an extra analysis of survival based on reasons for immigration among 
foreign-born (refugee, non-refugee, and unknown) in comparison to Sweden-born breast 
cancer patients. The definition of a refugee was based on the classification of the Swedish 
Migration Board: “a person who has applied for asylum and can stay in Sweden on refugee 
grounds”. A non-refugee immigrant was defined as a person accepted by Sweden on 
humanitarian grounds, family of a refugee, a worker, family of a worker, family not of 
refugee or worker and other non-refugee [210-212]. Missing information for reasons for 
immigration was defined as unknown. Among foreign-born patients with the first primary 
diagnosis of breast cancer, 1,037 (24.5%) had information about reasons for immigration, 
and 87 died due to any cause. A total of 249 refugee patients were included in the analysis; 
there were 23 deaths due to any cause in this group. Among foreign-born patients, 
information about stage was missing for 1,717 (40%). While 88 refugee patients (35,3%) 
also lacked this information (Tables 3 and 4). 
After adjustment for age at diagnosis, education, county of residence and CCI, we observed 
46% and 41% higher all-cause and excess mortality, respectively, for refugee women with 
stage III–IV disease (HR=1.46, 95% CI 0.68–3.15 and RER=1.41, 95% CI 0.64–3.12), 
compared with Sweden-born patients (Tables 3 and 4). In a later analysis including women 
with all stages and missing information together, the all-cause and excess mortality risks 
were decreased to 23% and 13%, respectively, for refugee women (Table 5). 
Refugee patients with stage III–IV cancer had 17% and 16% higher risk of  all-cause and 
excess mortality, respectively, compared with non-refugee patients (HR=1.17, 95% CI 
0.40–3.40 and RER=1.16, 95% CI 0.39–3.48) (Tables 6 and 7). 
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Table 3: Hazard ratio (HR) of all-cause mortality and 95% confidence interval (CI) among foreign-born, based on reasons for migration, and Sweden-
born breast cancer patients by tumor stage, in Sweden in 2004–2009. 
 Breast cancer stage 
  
 Stage I  Stage II  Stage III–IV  All stages  Missing 
 
         
Country of birth NO
a
  D
b 
HR* (95%CI)  NO
a
  D
b 
HR* (95%CI)  NO
a
  D
b 
HR* (95%CI)  NO
a
  D
b 
HR* (95%CI)  NO
a
  D
b 
HR* (95%CI) 
Sweden-born 8234 266 1 (Referent)  7635 847 1 (Referent)  1621 665 1 (Referent)  17490 1778 1 (Referent)  13546 1982 1 (Referent) 
Foreign-born 1136 24 0.67 (0.44-1.04)  1147 96 0.86(0.69-1.08)  232 93 1.20 (0.95-1.51)  2515 213 0.92 (0.79-1.06)  1717 205 1.03 (0.89-1.19) 
 Reasons for migration                    
 Refugee 64 1 1.08 (0.15-7.84)  80 7 1.16 (0.55-2.47)  17 7 1.46 (0.68-3.15)  161 15 1.43 (0.86-2.39)  88 8 1.05 (0.52-2.12) 
 Non-refugee 200 6 0.93 (0.37-2.35)  244 19 0.92 (0.56-1.50)  48 16 1.16 (0.67-1.99)  492 41 0.93 (0.67-1.30)  296 23 0.81 (0.53-1.23) 
 Unknown 872 17 0.61 (0.37-1.01)  823 70 0.83 (0.65-1.07)  167 70 1.19 (0.92-1.53)  1862 157 0.89 (0.75-1.05)  1333 174 1.06 (0.91-1.24) 
*Adjusted for age at diagnosis, education, county of residence, and comorbidity.  
a Number of women diagnosed with breast cancer. 
b Number of deaths. 
 
Table 4: Relative excess risk (RER) and 95% confidence interval (CI) among foreign-born, based on reasons for migration, and Sweden-born breast 
cancer patients by tumor stage, in Sweden in 2004–2009. 
 Breast cancer stage 
  
 Stage I  Stage II  Stage III–IV  All stages  Missing 
 
         
Country of birth NO
a
  D
b 
RER* (95%CI)  NO
a
  D
b 
RER* (95%CI)  NO
a
  D
b 
RER* (95%CI)  NO
a
  D
b 
RER* (95%CI)  NO
a
  D
b 
RER* (95%CI) 
Sweden-born 8234 266 1 (Referent)  7635 847 1 (Referent)  1621 665 1 (Referent)  17490 1778 1 (Referent)  13546 1982 1 (Referent) 
Foreign-born 1136 24 0.14 (0.01-1.83)  1147 96 0.75 (0.53-1.06)  232 93 1.21 (0.94-1.55)  2515 213 0.84 (0.67-1.04)  1717 205 1.05 (0.86-1.29) 
 Reasons for migration                    
 Refugee 64 1 NA  80 7 1.09 (0.47-2.53)  17 7 1.41 (0.64-3.12)  161 15 1.28 (0.70-2.33)  88 8 0.93 (0.40-2.16) 
 Non-refugee 200 6 NA  244 19 0.81 (0.42-1.55)  48 16 1.14 (0.64-2.01)  492 41 0.83 (0.53-1.28)  296 23 0.82 (0.49-1.36) 
 Unknown 872 17 NA  823 70 0.70 (0.46-1.05)  167 70 1.21 (0.92-1.59)  1862 157 0.82 (0.64-1.05)  1333 174 1.12 (0.89-1.39) 
*Adjusted for age at diagnosis, education, county of residence, and comorbidity.  
a Number of women diagnosed with breast cancer. 
b Number of deaths. 
  
  39 
 
Table 5: Hazard ratio (HR) and relative excess risk (RER) and 95% confidence interval 
(CI) among foreign-born, based on reasons for migration, and Sweden-born breast cancer 
patients, in Sweden in 2004–2009. 
 Breast cancer patients 
Country of birth NO
a
 D
b
 HR* (95% CI) RER* (95% CI) 
Sweden-born 31036 3760 1 (Referent) 1 (Referent) 
Foreign-born 4232 418 0.99 (0.89-1.11) 1.02 (0.88-1.17) 
 Refugee 249 23 1.23 (0.81-1.86) 1.13 (0.71-1.79) 
 Non-refugee 788 64 0.92 (0.71-1.20) 0.91 (0.66-1.25) 
  Family of refugee 168 2 0.73 (0.41-1.29) 0.76 (0.39-1.49) 
  Family not of refugee or worker 382 30 0.78 (0.54-1.13) 0.77 (0.47-1.24) 
  Humanitarian grounds 204 20 1.48 (0.95-2.31) 1.34 (0.79-2.23) 
  Worker 15 0 NA NA 
  Others 19 2 1.96 (0.48-8.00) 1.99 (0.40-9.80) 
 Unknown 3195 331 1.00 (0.89-1.12) 1.03 (0.88-1.21) 
*Adjusted for age at diagnosis, education, county of residence, tumor stage, and comorbidity.  
a Number of women diagnosed with breast cancer. 
b Number of deaths. 
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Table 6: Hazard ratio (HR) of all-cause mortality and 95% confidence interval (CI) among foreign-born breast cancer patients, based on reasons for 
migration, by tumor stage in Sweden in 2004–2009. 
 Breast cancer stage 
  
 Stage I  Stage II  Stage III–IV  All stages  Missing 
 
         
Reasons for migration NO
a
  D
b 
HR* (95% CI)  NO
a
  D
b 
HR* (95% CI)  NO
a
  D
b 
HR* (95% CI)  NO
a
  D
b 
HR* (95% CI)  NO
a
  D
b 
HR* (95% CI) 
Refugee 64 1 0.71 (0.08-6.58)  80 7 0.98 (0.40-2.42)  17 7 1.17 (0.40-3.40)  161 15 1.33 (0.72-2.44)  88 8 1.21 (0.54-2.74) 
Non-refugee 200 6 1 (Referent)  244 19 1 (Referent)  48 16 1 (Referent)  492 41 1 (Referent)  296 23 1 (Referent) 
Unknown 872 17 0.37 (0.11-1.22)  823 70 0.47 (0.25-0.89)  167 70 1.01 (0.48-2.12)  1862 157 0.75 (0.50-1.13)  1333 174 1.31 (0.79-2.17) 
*Adjusted for age at diagnosis, education, county of residence, and comorbidity.  
a Number of women diagnosed with breast cancer. 
b Number of deaths. 
 
 
Table 7: Relative excess risk (RER) and 95% confidence interval (CI) among foreign-born breast cancer patients, based on reasons for migration, by 
tumor stage in Sweden in 2004–2009. 
 Breast cancer stage 
  
 Stage I  Stage II  Stage III–IV  All stages  Missing 
 
         
Reasons for migration NO
a
  D
b 
RER* (95% CI)  NO
a
  D
b 
RER* (95% CI)  NO
a
  D
b 
RER* (95% CI)  NO
a
  D
b 
RER* (95% CI)  NO
a
  D
b 
RER* (95% CI) 
Refugee 64 1 NA  80 7 1.04 (0.37-2.88)  17 7 1.16 (0.39-3.48)  161 15 1.42 (0.69-2.94)  88 8 1.04 (0.38-2.80) 
Non-refugee 200 6 1 (Referent)  244 19 1 (Referent)  48 16 1 (Referent)  492 41 1 (Referent)  296 23 1 (Referent) 
Unknown 872 17 NA  823 70 0.41 (0.18-0.95)  167 70 0.97 (0.44-2.14)  1862 157 0.83 (0.48-1.45)  1333 174 1.25 (0.66-2.37) 
*Adjusted for age at diagnosis, education, county of residence, and comorbidity.  
a Number of women diagnosed with breast cancer. 
b Number of deaths. 
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5 DISCUSSION 
 
5.1 MAIN FINDINGS 
5.1.1 Study I 
In this nationwide cohort study in Sweden between 1961 and 2009, we observed a higher risk 
of all-site cancer mortality among persons with a low level of education compared with those 
who were highly educated regardless of sex and country birth. Compared with Sweden-born 
men, all-site cancer mortality was slightly higher among foreign-born men, whereas women 
born outside Sweden had a similar risk for all-site cancer mortality compared with Sweden-
born women. The results varied for site-specific cancers. Compared with Sweden-born 
individuals, those born outside Sweden had lower risks of colon, breast, and prostate cancer 
mortality but higher risks of lung and cervical cancer mortality. 
 
5.1.2 Study II 
In general, in this nationwide cohort study of all cancer patients aged over 45 years between 
1961 and 2009 in Sweden, we found a reduction in overall survival among foreign-born 
patients diagnosed with all types of cancer after the year 2000 compared with Sweden-born 
patients. The results were almost identical for both sexes regardless of duration of residence 
and age at diagnosis. Furthermore, the mortality trend was similar for prostate and breast 
cancer patients. 
 
5.1.3 Study III 
In this nationwide cohort study of breast cancer patients with regard to stage at diagnosis 
between 2004 and 2009 in Sweden, we found that all-cause and excess mortality decreased 
with increasing level of education regardless of country of birth. All-cause and excess 
mortality increased with increasing tumor size, number of lymph nodes involved, anatomic 
stage, presence of metastasis, and comorbidity particularly among foreign-born breast cancer 
patients. The risk of stage II tumor (stage I as baseline) was higher in all foreign-born patients 
and those born in Asia specifically compared with Sweden-born patients. The risk of all-
cause and excess mortality was higher in all foreign-born patients and also those born in 
Southern Europe and Asia with advanced cancer (stages III–IV), compared with Sweden-
born patients. 
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5.1.4 Reason for migration 
Refugees with breast cancer had higher (but not statistically significant) risks of both all-
cause and excess mortality, compared with Sweden-born patients. In the stratified analysis by 
stage, the risks were greatest at stages III–IV. In addition, compared with non-refugees, 
refugee patients had non-significantly higher risks of both all-cause and excess mortality with 
advanced cancer stages III–IV.  
 
 
5.2 INTERPRETATION OF FINDINGS 
 
5.2.1 Migration background and mortality 
All-site cancer  
Our finding of a higher risk of all-site cancer mortality among foreign-born men was in 
contrast with the findings of some previous studies [25, 134] but in line with others from the 
UK [137, 143]. The lower risk in our study among men born in Asia and in South-East Asia 
has been reported previously [137, 144, 145]. The higher risk among men born in Eastern and 
Southern Europe in our study is in contrast to results reported from Spain [134, 136, 145]. 
Among women, the finding of a similar risk of all-site cancer mortality among foreign-born 
and Sweden-born individuals in our study is in line with some previous results [25], but in 
contrast to others [134, 136, 213]. Similar lower risks among women born in Turkey, Asia, 
South-East Asia, Italy, East and North Africa, Southern Europe, and South America have 
been reported in some studies [134, 136, 137, 141, 143, 144, 147, 149, 214].  
The lower all-site cancer mortality among some migrants might be associated with factors 
such as the healthy migrant effect [92, 108, 134, 136, 141, 142]. Migrants who had a long 
duration of stay would have higher cancer mortality compared with those with a shorter 
duration of stay, which has been correlated with the healthy migrant effect [134, 215]. 
However, to our knowledge, there has been no precise data of the healthy migrant effect in 
Sweden. It is known that many migrant groups maintain their cultural habits and previous 
lifestyle. If these habits are a risk for various health conditions, they will increase the risk for 
many years in the host country [153]. In general, cultural background and lifestyle habits are 
associated with cancer mortality [216]. Traditional habits related to religion or to other 
cultural factors among migrants, such as lower consumption of alcohol, have been shown to 
be related to lower cancer mortality [141, 142, 153]. On the other hand, some groups have a 
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higher capacity for adoption of various forms of unhealthy behaviors as well as general risks 
related to life in urbanized environments [217]. As mentioned earlier, cancer is a very 
complex disease, known to be associated with many factors. Both genetic and environmental 
factors (including diet, obesity, physical activity, socioeconomic status, etc.) have been 
shown to effect both cancer incidence and mortality [134, 137, 139, 143, 144, 150].  
 
Specific cancer types 
Colon cancer 
The lower risk of colon cancer mortality among foreign-born men and women from Southern 
Europe and Turkey in our study was consistent with the results of another study [134]. By 
contrast, a higher risk was observed among foreign-born men and women from Middle 
Eastern countries in a study in California [218]. The differences in colon cancer mortality risk 
might be due to differences in lifestyle-related factors including alcohol consumption and diet 
[134, 219, 220].  
 
Lung cancer 
In our study, lung cancer mortality was higher among foreign-born men from Southern 
Europe and the former Soviet Union, in line with the results of previous studies [106, 145], 
and lower among foreign-born women from Asia and South America, which is also in 
agreement with reported results from the Netherlands [134, 136, 137, 143]. In contrast to our 
results, lower lung cancer mortality risks among foreign-born men from Asia, West Africa, 
and Turkey and among foreign-born women from Eastern Europe were observed in other 
studies [106, 137, 142, 143, 149]. The most probable explanations for the observed 
differences in lung cancer mortality among foreign-born compared with Sweden-born men 
and women are prevalence of smoking, the causal risk factor for lung cancer [106, 108, 134, 
136, 137, 139, 141-145, 150, 154, 221], and genetic factors [220]. Smoking varies by 
geographical region and sex. Unfortunately, reliable data on smoking among immigrants in 
Sweden are lacking. However, the results of a health survey in Stockholm County showed a 
lower prevalence of daily smoking among migrants born in Canada, USA, Britain, and 
Ireland, and a higher prevalence among migrants born in Eastern Europe, Iraq, Finland, Iran, 
Poland, the former Yugoslavia, Southern Europe, Bosnia, North Africa, Chile, and Turkey, 
compared with Sweden-born individuals (personal communication).  
Moreover, the same health survey showed a higher prevalence of smoking among men born  
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in Finland, the former Yugoslavia, Denmark, Chile, Iran, Southern Europe, North Africa, 
Iraq, Poland, Norway, Iceland, and Turkey, compared with Sweden-born men (personal 
communication). Of interest, we found higher cancer mortality among migrant men from 
several countries highlighted in the survey, including Finland, the former Yugoslavia, 
Denmark, Southern Europe, and Norway. Furthermore, the health survey showed a lower 
prevalence of daily smoking among women born in Central and Southern Africa and a higher 
prevalence among women born in the former Yugoslavia, Eastern Europe, Finland, Bosnia, 
Chile, and Turkey [39, 222]. The higher prevalence of daily smoking among migrant women 
born in Bosnia was correlated with our finding of higher cancer mortality among migrant 
women. 
In Malmo County, the prevalence of daily smoking was higher among both men and women 
born in Denmark/Norway, and men born in Poland and Arabic-speaking countries, than 
among Swedish men and women. The prevalence of smoking  was lower  in women born in 
Arabic-speaking countries [223]. Studies of prevalence of unhealthy behaviors and risk 
factors for coronary heart disease carried out among migrants in Sweden showed that 
prevalence of smoking was higher among immigrant men (in all subgroups) than Swedish 
men [224, 225]. A higher prevalence of smoking was observed in immigrant women from the 
Organization for Economic Cooperation and Development (OECD), Chile, and Poland, 
compared to Swedish women [224], whereas the prevalence was lower in women from Iran 
[224, 225].  
 
Stomach cancer 
The observed higher stomach cancer mortality risks among men born in South America and 
Eastern Europe and women born in most countries in Asia are supported by previous studies 
[106, 110, 138, 144, 147, 149, 152, 220]. The higher stomach cancer mortality risk among 
immigrants could be due to an increased incidence of stomach cancer as a result of a higher 
prevalence of Helicobacter pylori infection, genetic variation, and different dietary habits 
such as a higher consumption of salty foods [106, 149]. 
 
Prostate cancer 
A lower risk of prostate cancer mortality among foreign-born men has previously been 
demonstrated [106, 134, 137, 139, 219, 220, 226, 227]; this might be due to a true lower 
prostate cancer incidence [38, 143], genetic factors [155, 228], or to undetected prostate  
 
  45 
 
cancer among immigrants as a result of a lack of awareness among this group of the prostate-
specific antigen test. In contrast to our findings, a higher risk of prostate cancer mortality was 
observed previously among men born in South America [143, 144]. Screening is one of the 
main factors that affect the incidence of prostate cancer [38]. Of note, evidence shows that the 
decreased prostate cancer mortality does not appear to be a result of a prostate cancer 
screening [229, 230]. Lower prostate cancer risk in migrants is consistent with the fact that 
the countries they come from have lower incidence and mortality compared with the host 
country [147, 226, 231-233].    
Family history and race/ethnicity are other risk factors that are strongly linked to 
development of prostate cancer [228, 232, 234-241]. Men with family history for prostate 
cancer are known to have higher rate of mortality due that [242-244]. Men with two or more 
diagnosed relatives and/or men whose relatives were diagnosed with prostate cancer before 
the age of 65 years had a considerably increased mortality rate due prostate cancer [243]. 
However, findings differed for prostate cancer mortality among different racial/ethnic groups 
[245, 246]. A recent study indicated that black men in the UK have a poor awareness of 
prostate cancer risk [247]. Race disparities were also found for mortality rates, which were 
markedly higher in Afro-American men compared with white American men [238, 241, 248, 
249]. Conversely, Puerto Rican, Asian-American, Pacific Island, American Indian, native 
Alaskan, and Hispanic men all had lower mortality rates compared with white American men 
[241, 250, 251]. However, according to our calculation based on data from Statistics 
Sweden, the proportion of African migrant men among all foreign-born men in Sweden is 
low (about 8% in 2009) [252]. Therefore we believe the effect of racial factors on prostate 
cancer mortality cannot be excluded but, due the low number of African emigrants, such an 
effect may not be obvious.  
 
Breast cancer 
The observed lower risk of breast cancer mortality among foreign-born women has 
previously been reported including in women born in Asia, East Asia, South America, Chile, 
and Turkey migrating to other parts of the world [110, 134, 136, 137, 143, 144, 149, 154, 
219-221, 226, 253]. The observed lower risk of breast cancer mortality could be explained 
partly by a decreased breast cancer incidence in this group [37] or by death from other 
diseases such as cardiovascular disorders [254, 255]. However, the results of a previous study  
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in Sweden [37] indicate that the risk of mortality among immigrant breast cancer patients was 
higher after the year 2000, compared with patients born in Sweden. 
 
Cervical cancer 
The higher risk of cervical cancer mortality in our study has previously been observed among 
immigrant women compared with white women in the USA [256]. By contrast, immigrant 
women in the Netherlands had a lower risk of cervical cancer mortality [134]. The higher 
cervical cancer mortality among foreign-born women could be due to late detection of HPV 
infection among immigrant women (thus late diagnosis of cervical cancer) [133, 220, 257-
259], early life exposures in the country of origin, and disparities in the access to care. 
In the case of HPV infection, there are more than 100 types of HPV, or which least 13 have 
been associated with increased risk of several types of cancer including cervical cancer [260-
263]. In particular two HPV types, HPV16 and 18, are most strongly related to risk of cancer 
[264, 265]. HPV 16 and 18 are also recognized as inducers of approximately 70% of all 
cervical cancers cases [263]. Higher rates of HPV infection have been found in immigrant 
women, and this group has also been reported to have lower rates of participation in 
screening programs [258, 266]. In Sweden, the healthcare system has systematically 
developed effective screening strategies as an attempt toward cancer prevention. Immigrants 
from low and middle income countries had limited access to screenings in their home 
countries which unavoidably affects early diagnosis and thus mortality [263]. It is known that 
the cascade of cervical cancer development starts with dysplasia (cellular abnormalities and 
formation of precancerous lesions) [263, 267]. HPV infection can also induce dysplasia 
which is primarily mild which later often leads to fatal, invasive cervical cancer [268-274].  
 
5.2.2 Level of education and mortality 
During the study period (1961– 2009), we observed a higher risk of all-site cancer mortality 
in Sweden among individuals with a low level of education, except in the years between 1961 
and 1970; this was consistent with the results of studies conducted in Australia and Spain 
[193, 275]. This association between all-site cancer mortality and education level could be 
explained by different health-seeking behavior leading to late-stage cancer at diagnosis, less 
favorable lifestyle factors [276], and death from cancers with a poor prognosis and a higher 
prevalence among individuals with a low SEP, such as stomach cancer [275, 277] that 
leading to increased cancer mortality among individuals with low level of education. The  
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decreased mortality with decreasing level of education observed during the 1960s was 
supported by the findings of studies from Barcelona, Spain and from Puerto Rico [278, 279]. 
However, this should be interpreted with caution as the percentage of missing information on 
level of education was higher during the 1960s compared with other periods. 
 
5.2.3 Migration background and overall survival 
All-site cancer  
Next we focused on cancer patients aged over 45 years between 1961 and 2009 in Sweden to 
investigate the effect of migration background on all-cause mortality. Compared with 
Sweden-born patients, we observed higher overall survival among foreign-born patients 
between 1970 and 1990, which could be partly due to the composition of migrant populations 
in Sweden, with differences in terms of ethnicity and reasons for migration in different time 
periods [280]. In the 1940s the majority of immigrants were refugees from the Second World 
War, whereas in the 1950s and 1960s the labor market migrants from the Nordic countries 
and later from parts of Southern Europe and Turkey moved to Sweden [19]. Other reasons  
for the higher overall survival among foreign-born patients between 1970 and 1990, may be 
the result of the “healthy migrant effect” [28] and “salmon bias” [92] as well as the degree of 
acculturation and healthcare accessibility and utilization, mostly among those resident in 
Sweden for at least 15 years.  
Unclear trends in overall survival in our cohort between 1990 and 2000 may be explained by 
the huge diversity in ethnic status among those who immigrated to Sweden after the 1970s; 
the reasons for immigration changed from labor migration to asylum-seeking and fleeing 
from Iran and Latin America during the 1970s and 1980s [19]. Moreover, in the 1990s and at 
the beginning of the 2000s the largest groups of immigrants in Sweden were from the former 
communist countries in Eastern Europe and from Somalia and Iraq [18, 19].  
Lower levels of integration might account for a part of the overall increased risk of all-site 
mortality among foreign-born cancer patients in the period after the year 2000. Other reasons 
that might contribute to poor survival are detrimental health changes among migrants from 
war-torn regions [281] and low participation rates in screening programs [179, 180]. 
Previous studies have shown that low physical activity [282], high intake of total fat [283],  
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high alcohol intake [284], smoking [285, 286], or any individual cancer-related risk factor 
and its distribution between immigrants and the local-born population might underlie the 
differences in survival. 
 
Breast cancer  
Overall survival for patients with breast cancer varies between foreign- and Sweden-born, 
after year 2000 this difference increases in worsen survival for migrants. This could partially 
be explained by lower participation in mammography screening program among foreign born 
women [183], similar findings have been documented in Australia and Netherlands [177, 
287]. 
In our study, we observed later-stage disease presentation in foreign-born women. This is in 
agreement with findings in ethnic minorities in the USA [288, 289], New Zealand [290], 
Canada [291], and in some European studies conducted in England [114], Denmark [129], 
and Norway [170]. This delay might be due to low adherence to mammographic screening 
programs [292, 293], or cultural and behavioral aspects such as language and integration 
difficulties. In migrant populations, accesses to healthcare and SEP might also explain this 
delay [178, 294, 295]. Other factors involving poor access to medical services, delay in 
seeking healthcare, individual awareness of personal risk, lack of communication with 
healthcare professionals, and insufficient health promotion strategies [295] can also play a 
role in delayed diagnoses and further have an impact on the duration between diagnosis and 
treatment [296]. Moreover, a combination of differences in risk factors and biology [291, 
297] and age at diagnosis in foreign-born women might partly explain this. Differences in 
the clinical and biological characteristics between young and older patients with breast 
cancer as well as across different racial/ethnic groups have been demonstrated. In 
comparison to older patients, in younger patients diagnosed with breast cancer the tumor is 
more aggressive and presents with a more advanced tumor stage, larger tumor size, and 
higher tumor grade [298-301]. Similar clinical characteristics have also been found among 
African-American and  Hispanic patients with breast cancer living in the USA [302, 303], 
and patients living in Africa, Eastern Europe, Middle East, South America, Mexico, and 
Caribbean [304]. 
It has been suggested that differences in the distribution of stage at diagnosis for patients 
with breast cancer and subsequent disparity in mortality between immigrants and native 
populations may be partly due to low commitment to mammography screening [168, 181, 
182].  
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We observed higher all-cause and excess mortality among foreign-born compared with 
Sweden-born patients with the same tumor stage, therefore poorer prognosis among 
migrant patients with advanced tumor stages III–IV cannot be explained by low 
participation in mammography screening. This observation has also been reported 
previously in several ethnic groups living in the USA, including Afro-Americans, Native 
Americans, and migrants from Asia and Central and South America [167, 168]. 
Comorbidity has previously been associated with both lower survival [305-307] and less 
aggressive treatment [173, 308] in patients with breast cancer. In this study, we observed 
lower survival in breast cancer patients with comorbid diseases, although the poorer 
prognosis in foreign-born patients with stage III–IV tumors could not be attributed to 
comorbidity (as this was adjusted for in the multivariable analysis). Furthermore, factors 
such as obesity [309], physical inactivity [310, 311], and weight gain after breast cancer 
diagnosis [312] have also been associated with high mortality in patients with breast cancer.  
 
5.2.4 Level of education and overall survival 
Reduced all-cause and excess mortality associated with a higher level of education among 
patients with breast cancer regardless of country of birth has previously been demonstrated in 
Sweden [313, 314] and other countries [310]. The use of preventive healthcare such as 
mammography screening may be related to educational level [315]. Late stage at diagnosis of 
breast cancer and worse prognosis may be due to non-participation in mammography 
screening [316]. However, in our project, the opposite association between education and 
all-cause and excess mortality remained after adjustment for tumor stage.  
 
5.2.5 Reason for migration in breast cancer patients 
Among women diagnosed with breast cancer, we found non-significantly higher risks of both 
all-cause and excess mortality in refugee women, compared with Sweden-born patients. In 
the stratified analysis by stage, the increase in risk was greatest in advanced disease (stages 
III–IV). Furthermore, compared with non-refugee patients, we found non-significantly higher 
risks of both all-cause and excess mortality among refugee women with stage III–IV cancer. 
The reason the risk increases were not significant may be related to low power and number of 
patients among refugees especially in the subgroup with stage III–IV cancer (17 patients and  
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seven deaths). It is noteworthy that there is a lack of knowledge about survival for breast 
cancer patients by stage in subpopulations of migrants (such as refugees), therefore further 
research is needed in this area. A lack of statistically significant findings may also indicate 
efficiency and availability of the Swedish healthcare system. In Sweden, adult refugees have 
access to healthcare for urgent conditions from the day they seek asylum [317]. All breast 
cancer patients are treated in a similar manner. 
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6 METHODOLOGICAL COSIDERATIONS 
 
6.1 STRENGTHS 
The main strength of present thesis is that all included studies are cohort studies based on 
several unique and high-quality Swedish registers including all individuals and cancer cases 
in Sweden. The Cause of Death Register ensured complete follow-up for all individuals 
including patients with cancer. Almost complete information was available on the main 
exposure of the study (country of birth) including foreign-born and Sweden-born individuals 
in Sweden. In addition, because of the cohort design with a long follow-up period and the 
large sample size in our studies, we were able to either adjust for some potential confounding 
factors between exposures (country of birth and education level) and outcomes (cancer 
mortality and all-cause mortality of patients with cancer) or perform a multidimensional 
stratified analysis. 
 
6.2 LIMITATIONS 
An important limitation is the lack of clinical data such as stage of cancer for the whole study 
period for Studies I and II and treatment for all studies. Moreover, we also lacked genetic data 
and information on environmental factors, such as social support, access to healthcare 
services, dietary habits, smoking, alcohol consumption, physical activities, degree of 
acculturation, or any individual cancer-related risk factors, which may have affected the 
observed results. In addition, we did not have access to other indicators of SEP such as 
occupation and income for whole study period in the three studies in this thesis.  
 
6.3 BIAS 
In statistics, bias occurs when the estimator‟s expected value is not equal to the true value of 
the parameter. In an epidemiological study, bias is defined as any systematic error that 
distorts the estimate of the association between exposure and outcome that cannot be 
controlled for in the analysis stage. The three main forms of bias in epidemiological studies 
are selection bias, information bias and salmon bias. 
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6.3.1 Selection bias 
Selection bias is defined as a systematic error in the selection of samples in the population. 
This occurs when an unrepresentative group is selected in the study population. Immigrants 
are most likely a self-selected subgroup of the original population and might not represent the 
whole population in their home countries. Thus, the interpretation of findings in immigrant 
groups can be limited and might not be generalizable to the whole population in their 
countries of birth.  
Loss of follow-up is a problem particularly associated with cohort studies. If there is a 
difference between participants lost to follow-up with regards to the exposure and outcome 
compared to those who remain in the study, this may lead to bias. Register-based follow-up 
among immigrants is another issue that needs to be considered if they leave Sweden without 
reporting to the authorities. This leads to over-coverage in the TPR and subsequently 
underestimation of the outcome under study. Statistics Sweden estimated that there is as 
much as 10% over-coverage of immigrants in the TPR [23]. 
 
6.3.2 Information bias 
Information bias is a systematic error that occurs as a result of incorrect or inaccurate 
classification of exposure or outcome and this may result in either non-differential or 
differential misclassification. Non-differential misclassification means that the frequency of 
errors in either exposure or outcome is approximately the same in the comparison groups. 
Otherwise the misclassification will be differential. Non-differential misclassification is 
generally less problematic because it can only lead to a dilution of the real association. 
However, differential misclassification may lead to underestimation or overestimation of 
the real association. Differential misclassification of the outcome among an exposed group 
and an unexposed group is more likely to lead to overestimation and underestimation, 
respectively, and similarly for a misclassified exposure. 
 
6.3.3 Salmon bias 
According to the salmon bias hypothesis, immigrants in poorer health may return to their 
country of birth prior to death [92, 318-321]. This is more likely to apply to older migrants 
for whom health problems may be more prevalent [318, 319]. In the case of return migration,  
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deaths are thus recorded in the country of birth rather than the host country [320]. Return  
migration might be due to family support and the cultural importance of family ties, and 
lower cost of living, greater access to healthcare, or to other factors in the country of birth 
[92, 319, 321].  
Swedish immigrants who undergo salmon bias are often registered as deceased in the Cancer 
Death Register. However, the cause of death is not always registered for immigrants. 
Therefore in Study I, because the outcome is mortality due to cancer and death might be due 
to other causes, it is possible that cause of death was in fact due to cancer but we may have 
considered the death due to other causes. This would lead to differential misclassification of 
outcome as this problem is not encountered among Sweden-born individuals. However, we 
believe that it is unlikely that this would have affected our results in Study I, because the 
percentage of immigrants who left Sweden before death was very small. Regarding 
misclassification of country of birth, to our knowledge there is no evidence indicating any 
major problems related to being registered either as born inside or outside Sweden in our 
studies regardless of outcome. 
It is unlikely that misclassification of either exposure or outcome occurred because of the 
register-based nature of data in our studies, virtually complete information on country of 
birth (foreign-born and Sweden-born), and completeness of the Swedish health registers. 
According to the salmon bias hypothesis, foreign-born patients who return to their country of 
birth are exposed to higher mortality risks than those who stay in the host county. The results 
of some studies were consistent with this notion [319]. In addition, after repatriation, the 
mortality rate may be increased in their native country [92]. Return migration leads to an 
underestimation of the mortality rates among foreign-born individuals in the host country [92, 
142, 322]. Death rates are calculated using all events observed during a given period divided 
by the baseline population. However, regardless of the health condition of the return 
migrants, a bias in the estimated mortality rates will result, because the return migrants have 
generally poorer health in comparison with those who remain in the host county [92, 318]. 
However, the finding of lower mortality among Latin Americans in the USA does not support 
the salmon bias hypothesis [92]. 
In our project, differences in cancer mortality among migrants compared with the host 
population might be related to the return of migrants in poor health to their country of  
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origin prior to death [108, 141, 142]. Compared to our results (Study I), a lower risk of all-
site cancer mortality has been reported among Mexican women in the USA [323]. Lack of 
reporting about reverse emigration (back to the home country) among elderly and ill 
individuals prior to death might be associated with the observed decrease in all-site cancer 
mortality in this group [141, 142, 153]. However, the opposite findings of a higher risk in 
foreign-born men and similar risk in foreign-born women do not support this hypothesis. 
Furthermore, the higher overall survival among foreign-born patients between 1970 and 1990 
(Study II) may be explained by the salmon bias hypothesis [92]. However, studies have found 
that immigrants who return to their country of birth actually have lower survival rates [166, 
187].   
It is important to note that we cannot determine the impact of salmon bias on our findings. 
Salmon bias may have led to an underestimation of the mortality rates and/or overestimation 
of the survival rates. This is an important issue that must be considered. Because we do not 
have access to precise data on return migration of foreign-born individuals, the impact of 
salmon bias in Sweden cannot be excluded. To obtain an estimation of the effect we analyzed 
5-year survival for breast cancer patients older than 60 years of age diagnosed between 1961 
and 2005 and followed from 1961 to 2009 by country of birth in Sweden. We found that 
women from Chile, Greece, and Iran had higher rates of survival (86%, 79%, and 77%, 
respectively) than both Sweden-born (62%) and all foreign-born (69%) women. Of interest, 
we found that cancer mortality was lowest in migrants (both sexes) born in Iran and Greece 
compared with those born in Sweden (Study I). We assume that salmon bias may have had an 
effect on our results in these migrant groups. In the longer term, the results of the sensitivity 
analysis showed that the proportion of individuals who were 100 years of age and older was 
very low and similar among Sweden-born and foreign-born groups, thus further refuting the 
hypothesis of non-reported emigration of older foreign-born men and women.  
 
6.4 CONFOUNDING 
The purpose of epidemiological studies is to find a real association between an exposure 
and an outcome. However, in practice, it is uncommon to find a real association and usually 
the association is distorted by another factor, known as a confounder. This occurs when 
another exposure or risk factor is associated with both the exposure and the outcome (but is 
not part of the causal pathway between them) and is able to distort their association.  
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Uncontrolled confounding leads to a misleading association between the exposure and 
outcome and should be controlled. The usual ways to control for confounding are either in 
the study design; randomization, matching, and restriction, or in the analysis; stratification 
and as adjustments in the regression model. The benefit of using regression models is to be 
able to control for more than one confounder simultaneously [324].  
In this thesis, which includes three studies, we identified and controlled for several possible 
confounders based on previous literature and knowledge of the field. For association 
between country of birth as the main exposure and cancer mortality and survival after 
cancer diagnosis as outcomes, we identified several potential confounding factors to control 
by adjustment in the analyses and also by stratification.  
The most important confounders in epidemiological studies are non-modifiable variables 
such as age and sex. Differences in age distribution between immigrants and Sweden-born 
individuals (older age among those born in Sweden), especially for the cancers studied, 
might confound the comparison of cancer mortality and survival after cancer diagnosis in 
our studies. Thus, in Study I, age at follow-up as a potential confounder was controlled in 
the analyses and sex as another potential confounder was controlled by stratification. 
Further, ASRs were calculated using the world population as the standard in Study I to 
adjust only for age. In Study II, age at diagnosis for patients with cancer as a potential 
confounder was controlled in the analyses and sex was controlled by stratification. In Study 
III, age at breast cancer diagnosis as a potential confounder was controlled in the analyses. 
Level of education is one of the most basic indicators of SEP; health awareness that could 
affect health outcome and lifestyle is more related to literacy and level of education than 
occupation and income [325, 326], especially in Sweden with a good healthcare system. 
Furthermore, attained level of education is a more stable and standard indicator of SEP that 
is comparable between different studies. We indicated the effect of SEP on the risks by 
stratification of exposure; the risks decreased with increasing level of education however 
this effect was more evident for foreign-born men and for Sweden-born women. Thus, as 
another potential confounder, we adjusted for the highest level of education as an indicator 
of SEP when applicable in all analyses in this thesis.  
Moreover, there were other potential confounders in the studies such as calendar period at  
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baseline in Study I (which was controlled in the analyses as adjustment), duration of 
residence for foreign-born individuals and the calendar year of diagnosis in Study II 
(controlled by stratified analysis), and medical county of residence, comorbidity and 
anatomic stage, when applicable, in Study III (controlled in the analyses as adjustments, 
because distribution differences of these variables between immigrants and Sweden-born 
patients might confound the comparison of the risks).  
Finally, we lacked information on environmental factors, such as social support, access to 
healthcare services, dietary habits, smoking, alcohol consumption, and physical activities, 
which might have had an impact on the association between country of birth as the main 
exposure and cancer mortality and survival after cancer diagnosis as outcomes. 
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7 CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES 
 
 The decreasing overall cancer mortality trend in men but not women over the past 
two decades, regardless of country of birth, suggests the need for studies to identify 
the factors that influence this gender disparity in mortality. 
 
 The slight higher overall cancer mortality among foreign-born men compared with 
Sweden-born men indicates that studies are needed to investigate the mechanism(s) 
underlying the differences in cancer mortality among immigrants and Sweden-born 
men. 
 
 The association between low level of education and increased overall cancer 
mortality as well as poor survival after breast cancer diagnosis might be reduced by 
educating cancer patients and systematically improving care for patients with a low 
level of education.   
 
 Further studies with detailed clinical data are needed to understand the reasons 
behind the higher all-cause mortality after the year 2000 among foreign-born 
patients with all-site, breast and prostate cancers need these inequities. 
 
 
 The observed poor prognosis among foreign-born breast cancer patients with 
advanced-stage disease at diagnosis suggests that further studies with detailed 
patient and clinical data are needed. 
 
 As the power for results of refugees was low, further studies with appropriate power 
and longer follow-up are needed. 
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